| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 7.13e-09 | 4 | 185 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 7.13e-09 | 4 | 185 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 7.13e-09 | 4 | 185 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 3.54e-08 | 5 | 185 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 3.54e-08 | 5 | 185 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 3.54e-08 | 5 | 185 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 3.54e-08 | 5 | 185 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 3.54e-08 | 5 | 185 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 3.54e-08 | 5 | 185 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 3.54e-08 | 5 | 185 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.05e-07 | 6 | 185 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.44e-07 | 7 | 185 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 4.85e-07 | 8 | 185 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 4.85e-07 | 8 | 185 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 4.85e-07 | 8 | 185 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 8.67e-07 | 9 | 185 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 8.67e-07 | 9 | 185 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 8.96e-07 | 20 | 185 | 5 | GO:0004303 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.43e-06 | 10 | 185 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.43e-06 | 10 | 185 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.24e-06 | 11 | 185 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | NADPH binding | 3.63e-06 | 26 | 185 | 5 | GO:0070402 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH3 MYH13 MYO7A ATAD5 MYH7B NVL PEX1 AK9 SMC2 DHX30 DNAH12 ATAD2B DNAH17 ERCC6L2 MACF1 MTREX DNAH8 DYNC1H1 HSP90AB1 | 4.58e-06 | 614 | 185 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 6.64e-06 | 14 | 185 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 6.64e-06 | 14 | 185 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.24e-05 | 33 | 185 | 5 | GO:0033764 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.43e-05 | 118 | 185 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.45e-05 | 34 | 185 | 5 | GO:0016628 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.97e-05 | 18 | 185 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | NADP binding | 2.33e-05 | 62 | 185 | 6 | GO:0050661 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.88e-05 | 39 | 185 | 5 | GO:0016229 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 6.56e-05 | 24 | 185 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 ATAD5 NVL PEX1 AK9 SMC2 DHX30 DNAH12 ATAD2B MACF1 MTREX DNAH8 DYNC1H1 HSP90AB1 | 6.59e-05 | 441 | 185 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 MYH3 SYNPO2 MYH13 OFD1 MYO7A MYH7B CAMK2B NUMA1 MYRIP GBP3 DYSF SPAG5 MPRIP NF1 BAIAP2L1 IFT88 PLEKHM2 SYNE2 CEP135 FSCN2 MACF1 VCL HSP90AB1 | 8.29e-05 | 1099 | 185 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 8.54e-05 | 2 | 185 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 9.09e-05 | 26 | 185 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.06e-04 | 27 | 185 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.22e-04 | 11 | 185 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.23e-04 | 28 | 185 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 SYNPO2 MYH13 MYO7A MYH7B CAMK2B MYRIP GBP3 MPRIP BAIAP2L1 SYNE2 FSCN2 MACF1 VCL | 1.57e-04 | 479 | 185 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.62e-04 | 30 | 185 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 2.09e-04 | 32 | 185 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.09e-04 | 32 | 185 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | ADP-D-ribose binding | 2.55e-04 | 3 | 185 | 2 | GO:0072570 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 2.55e-04 | 3 | 185 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 2.73e-04 | 62 | 185 | 5 | GO:0016627 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.71e-04 | 37 | 185 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.12e-04 | 38 | 185 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 5.02e-04 | 40 | 185 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 5.06e-04 | 4 | 185 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | chromatin binding | PCGF1 NSD2 TSPY3 TSPY2 MACROH2A1 TSPY8 TSPY1 SMC2 FOXA2 PHC1 DHX30 DNTTIP1 GTF2H1 ATAD2B EXO1 TSPY10 MACROH2A2 | 5.34e-04 | 739 | 185 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.06e-04 | 42 | 185 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | lipid binding | OMA1 NUMA1 SMURF1 GSDMB PEX1 GBP3 AKR1C4 DYSF AKR1C1 AKR1C2 NF1 SCUBE2 APOLD1 OSBPL1A AKR1C3 ALB SMPD3 LTF CADPS2 ARAP2 | 8.70e-04 | 988 | 185 | 20 | GO:0008289 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.01e-03 | 48 | 185 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.19e-03 | 127 | 185 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | cadherin binding | EPS15 SLK RTN4 UNC45A MPRIP BAIAP2L1 MACF1 BAIAP2 VCL HSP90AB1 | 1.28e-03 | 339 | 185 | 10 | GO:0045296 |
| GeneOntologyMolecularFunction | actin filament binding | 1.29e-03 | 227 | 185 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.35e-03 | 130 | 185 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.80e-03 | 56 | 185 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.83e-03 | 138 | 185 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.91e-03 | 95 | 185 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2.32e-03 | 60 | 185 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 2.94e-03 | 9 | 185 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.21e-03 | 107 | 185 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | histone binding | 3.37e-03 | 265 | 185 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | histone H4K20 methyltransferase activity | 3.66e-03 | 10 | 185 | 2 | GO:0042799 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.06e-03 | 70 | 185 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 ATAD5 TRPM2 NVL PEX1 GBP3 AK9 SMC2 DHX30 DNAH12 ATAD2B MACF1 MTREX DNAH8 DYNC1H1 HSP90AB1 | 5.09e-03 | 839 | 185 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 ATAD5 TRPM2 NVL PEX1 GBP3 AK9 SMC2 DHX30 DNAH12 ATAD2B MACF1 MTREX DNAH8 DYNC1H1 HSP90AB1 | 5.15e-03 | 840 | 185 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 ATAD5 TRPM2 NVL PEX1 GBP3 AK9 SMC2 DHX30 DNAH12 ATAD2B MACF1 MTREX DNAH8 DYNC1H1 HSP90AB1 | 5.15e-03 | 840 | 185 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 ATAD5 NVL PEX1 GBP3 AK9 SMC2 DHX30 DNAH12 ATAD2B MACF1 MTREX DNAH8 DYNC1H1 HSP90AB1 | 5.80e-03 | 775 | 185 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 5.97e-03 | 78 | 185 | 4 | GO:0003725 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 6.27e-09 | 4 | 185 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 6.27e-09 | 4 | 185 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 6.27e-09 | 4 | 185 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 6.27e-09 | 4 | 185 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 6.73e-09 | 9 | 185 | 5 | GO:0007506 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 3.11e-08 | 5 | 185 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 3.11e-08 | 5 | 185 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 3.11e-08 | 5 | 185 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 3.11e-08 | 5 | 185 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 3.11e-08 | 5 | 185 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 3.11e-08 | 5 | 185 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 9.27e-08 | 6 | 185 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 9.27e-08 | 6 | 185 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.15e-07 | 7 | 185 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.15e-07 | 7 | 185 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 2.15e-07 | 7 | 185 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 7.62e-07 | 9 | 185 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.26e-06 | 10 | 185 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.26e-06 | 10 | 185 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.26e-06 | 10 | 185 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.26e-06 | 10 | 185 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.26e-06 | 10 | 185 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | parturition | 1.28e-06 | 22 | 185 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.97e-06 | 11 | 185 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.97e-06 | 11 | 185 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | ROCK2 SYNPO2 CAMK2B NUMA1 MACROH2A1 SMC2 NCAPG2 SPAG5 CRACD BAIAP2L1 IFT88 VPS35 CEP135 CCL11 SMPD3 BAIAP2 ESPL1 DYNC1H1 | 4.44e-06 | 574 | 185 | 18 | GO:0010638 |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 5.85e-06 | 14 | 185 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 5.85e-06 | 14 | 185 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 7.92e-06 | 15 | 185 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.05e-05 | 16 | 185 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.05e-05 | 16 | 185 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 1.45e-05 | 122 | 185 | 8 | GO:0006334 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | BDP1 CAND1 CENPC TSPY3 TSPY2 MACROH2A1 TSPY8 TSPY1 ATAD2B TSPY10 MACROH2A2 | 1.62e-05 | 249 | 185 | 11 | GO:0065004 |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 1.74e-05 | 18 | 185 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ROCK2 SYNPO2 SLK CAND1 RTN4 BAG5 TRPM2 NUMA1 RAPGEF1 GBP3 HAUS3 SPAG5 CRACD PPP2R5B BAIAP2L1 IFT88 SACS SYNE2 VPS35 CEP135 MACF1 CCL11 SMPD3 BAIAP2 DYNC1H1 VCL | 2.31e-05 | 1189 | 185 | 26 | GO:0044087 |
| GeneOntologyBiologicalProcess | cilium movement | OFD1 PGK2 CFAP54 DNAH12 TMEM232 IFT88 DNAH17 TMF1 DNAH8 DYNC1H1 CCDC40 | 2.50e-05 | 261 | 185 | 11 | GO:0003341 |
| GeneOntologyBiologicalProcess | regulation of keratinocyte differentiation | 2.80e-05 | 40 | 185 | 5 | GO:0045616 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.33e-05 | 21 | 185 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 3.33e-05 | 21 | 185 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 3.33e-05 | 21 | 185 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 3.33e-05 | 21 | 185 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 3.33e-05 | 21 | 185 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ROCK2 SYNPO2 CAND1 KALRN CAMK2B NUMA1 SMURF1 RAPGEF1 GBP3 MACROH2A1 SMC2 NCAPG2 SPAG5 CRACD PPP2R5B NF1 BAIAP2L1 IFT88 VPS35 CEP135 AHSG MACF1 CCL11 SMPD3 BAIAP2 ESPL1 PLXNA1 DYNC1H1 | 3.48e-05 | 1366 | 185 | 28 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of spindle assembly | 3.85e-05 | 8 | 185 | 3 | GO:1905832 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 4.04e-05 | 22 | 185 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 4.04e-05 | 22 | 185 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 4.04e-05 | 22 | 185 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 4.34e-05 | 142 | 185 | 8 | GO:0034728 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 4.85e-05 | 23 | 185 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 4.85e-05 | 23 | 185 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ROCK2 MYH3 SYNPO2 SLK MYO7A KRT84 NUMA1 HAUS3 KLHL41 DYSF CRACD NF1 BAIAP2L1 IFT88 FSCN2 AKAP13 CCL11 BAIAP2 KRT38 KRT37 DYNC1H1 HSP90AB1 | 5.00e-05 | 957 | 185 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 SLK OFD1 NUMA1 PEX1 HAUS3 SGO1 DYSF PGK2 SPAG5 CFAP54 DNAH12 TMEM232 IFT88 DNAH17 SYNE2 CEP135 TMF1 MACF1 ESPL1 DNAH8 DYNC1H1 CCDC40 | 7.81e-05 | 1058 | 185 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 8.03e-05 | 26 | 185 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | ROCK2 SYNPO2 NUMA1 SPAG5 CRACD BAIAP2L1 CCL11 BAIAP2 DYNC1H1 | 1.01e-04 | 205 | 185 | 9 | GO:0051495 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | ROCK2 ATAD5 CAMK2B NUMA1 MACROH2A1 SMC2 NCAPG2 SPAG5 SMPD3 ESPL1 DYNC1H1 | 1.08e-04 | 307 | 185 | 11 | GO:0090068 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.08e-04 | 28 | 185 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.21e-04 | 210 | 185 | 9 | GO:0060294 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.25e-04 | 29 | 185 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.25e-04 | 29 | 185 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | postsynapse organization | ROCK2 SORBS2 KALRN CAMK2B POTEF RTN4 POTEE NF1 VPS35 BAIAP2 POTEI | 1.28e-04 | 313 | 185 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.30e-04 | 212 | 185 | 9 | GO:0000070 | |
| GeneOntologyBiologicalProcess | chromosome separation | 1.41e-04 | 88 | 185 | 6 | GO:0051304 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.45e-04 | 215 | 185 | 9 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.45e-04 | 215 | 185 | 9 | GO:0001539 | |
| GeneOntologyBiologicalProcess | chromosome organization | OFD1 CENPC MTERF1 KMT5A NUMA1 MACROH2A1 SMC2 SGO1 NCAPG2 SPAG5 ZWINT DHX30 PARP4 EXO1 ESPL1 TOP3A HSP90AB1 | 1.56e-04 | 686 | 185 | 17 | GO:0051276 |
| GeneOntologyBiologicalProcess | positive regulation of chromosome separation | 1.63e-04 | 31 | 185 | 4 | GO:1905820 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.63e-04 | 31 | 185 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 1.85e-04 | 32 | 185 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.09e-04 | 33 | 185 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | ROCK2 EPS15 SORBS2 DPP10 KALRN NSD2 CAMK2B CAMK2G RTN4 TRPM2 NUMA1 NVL MYRIP MACROH2A1 FOXA2 SPAG5 UBL5 NF1 PLEKHM2 VPS35 CEP135 DYNC1H1 VCL HSP90AB1 | 2.24e-04 | 1212 | 185 | 24 | GO:0060341 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.35e-04 | 34 | 185 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | angiogenic sprout fusion | 2.39e-04 | 3 | 185 | 2 | GO:0120077 | |
| GeneOntologyBiologicalProcess | cell adhesion involved in sprouting angiogenesis | 2.39e-04 | 3 | 185 | 2 | GO:0120078 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | ROCK2 SYNPO2 CAND1 NUMA1 GBP3 SPAG5 CRACD PPP2R5B BAIAP2L1 IFT88 CEP135 CCL11 SMPD3 BAIAP2 DYNC1H1 | 2.53e-04 | 582 | 185 | 15 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of epidermal cell differentiation | 2.54e-04 | 63 | 185 | 5 | GO:0045604 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 2.64e-04 | 35 | 185 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 2.64e-04 | 35 | 185 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 2.95e-04 | 36 | 185 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 2.95e-04 | 36 | 185 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 2.98e-04 | 15 | 185 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | chromosome segregation | OFD1 CENPC KMT5A NUMA1 HAUS3 SMC2 SGO1 NCAPG2 SPAG5 ZWINT ESPL1 DYNC1H1 TOP3A | 3.04e-04 | 465 | 185 | 13 | GO:0007059 |
| GeneOntologyBiologicalProcess | regulation of protein localization | ROCK2 EPS15 SORBS2 DPP10 KALRN NSD2 CAMK2B CAMK2G RTN4 TRPM2 NUMA1 NVL MYRIP MACROH2A1 FOXA2 UBL5 NF1 PLEKHM2 VPS35 CEP135 VCL HSP90AB1 | 3.08e-04 | 1087 | 185 | 22 | GO:0032880 |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 3.64e-04 | 38 | 185 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | OFD1 CENPC KMT5A NUMA1 SMC2 SGO1 NCAPG2 SPAG5 ZWINT ESPL1 DYNC1H1 | 3.86e-04 | 356 | 185 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 4.10e-04 | 107 | 185 | 6 | GO:0051310 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ROCK2 OMA1 SYNPO2 CAMK2B TRPM2 NUMA1 HAUS3 MACROH2A1 SMC2 DYSF NCAPG2 SPAG5 ZWINT CRACD BAIAP2L1 IFT88 SYNE2 VPS35 CEP135 AKAP13 CCL11 SMPD3 BAIAP2 ESPL1 DYNC1H1 | 4.12e-04 | 1342 | 185 | 25 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 4.43e-04 | 71 | 185 | 5 | GO:0045682 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 4.45e-04 | 40 | 185 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | folic acid catabolic process | 4.74e-04 | 4 | 185 | 2 | GO:0046657 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I | 4.74e-04 | 4 | 185 | 2 | GO:1901837 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 4.95e-04 | 254 | 185 | 9 | GO:0000819 | |
| GeneOntologyBiologicalProcess | neuron projection development | ROCK2 WDR36 KALRN MYO7A CAMK2B POTEF CAMK2G RTN4 BAG5 SMURF1 CASP6 RAPGEF1 RNF157 POTEE SEMA3D PPP2R5B NF1 IFT88 MACF1 SEMA6A BAIAP2 POTEI PLXNA1 VCL | 5.22e-04 | 1285 | 185 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 5.37e-04 | 42 | 185 | 4 | GO:0070269 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 5.37e-04 | 42 | 185 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | mesoderm development | 5.48e-04 | 157 | 185 | 7 | GO:0007498 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ROCK2 MYH3 SYNPO2 MYO7A MYH7B POTEF TRPM2 MYRIP KLHL41 POTEE CRACD NF1 BAIAP2L1 SYNE2 FSCN2 AKAP13 CCL11 BAIAP2 POTEI | 5.70e-04 | 912 | 185 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 SYNPO2 OFD1 CENPC MYO7A NUMA1 SMURF1 HAUS3 KLHL41 SPAG5 DHX30 CFAP54 IFT88 CEP89 DNAH17 SYNE2 CEP135 TMF1 AKAP13 DNAH8 DYNC1H1 CCDC40 | 5.73e-04 | 1138 | 185 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 5.90e-04 | 316 | 185 | 10 | GO:0140014 | |
| GeneOntologyBiologicalProcess | positive regulation of keratinocyte differentiation | 6.19e-04 | 19 | 185 | 3 | GO:0045618 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 7.00e-04 | 45 | 185 | 4 | GO:0008207 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 SYNPO2 SORBS2 MYH13 KALRN MYO7A MYH7B POTEF MYRIP GBP3 MPRIP POTEE BAIAP2L1 FSCN2 MACF1 AKAP13 BAIAP2 POTEI VCL | 9.27e-07 | 576 | 185 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | LRRC39 MYH3 SYNPO2 SORBS2 MYH13 MYH7B POTEF KRT84 NUMA1 HAUS3 KLHL41 DYSF SPAG5 POTEE PARP4 DNAH12 TMEM232 DNAH17 SYNE2 MACF1 AKAP13 BAIAP2 POTEI DNAH8 KRT38 KRT37 DYNC1H1 VCL | 1.76e-06 | 1179 | 185 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | LRRC39 MYH3 SYNPO2 SORBS2 MYH13 MYH7B POTEF KRT84 NUMA1 HAUS3 KLHL41 DYSF SPAG5 POTEE PARP4 DNAH12 TMEM232 DNAH17 SYNE2 MACF1 AKAP13 BAIAP2 POTEI DNAH8 KRT38 KRT37 DYNC1H1 VCL | 2.01e-06 | 1187 | 185 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | POTEF KRT84 NUMA1 HAUS3 DYSF SPAG5 POTEE PARP4 DNAH12 TMEM232 DNAH17 MACF1 AKAP13 BAIAP2 POTEI DNAH8 KRT38 KRT37 DYNC1H1 VCL | 1.46e-04 | 899 | 185 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.76e-04 | 32 | 185 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.76e-04 | 32 | 185 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | motile cilium | OFD1 AKAP3 SLCO6A1 PGK2 DNAH12 TMEM232 IFT88 CEP89 DNAH17 DNAH8 CCDC40 | 3.37e-04 | 355 | 185 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | centrosome | ROCK2 OFD1 CAMK2B NUMA1 HAUS3 MACROH2A1 CCNJ SGO1 DYSF SPAG5 IFT88 CEP89 CCNB3 CEP135 ERCC6L2 ESPL1 DYNC1H1 | 5.08e-04 | 770 | 185 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 6.66e-04 | 45 | 185 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 6.66e-04 | 45 | 185 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | myofibril | 7.55e-04 | 273 | 185 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 7.65e-04 | 5 | 185 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.15e-03 | 290 | 185 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | dynein complex | 1.33e-03 | 54 | 185 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.36e-03 | 25 | 185 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | myosin filament | 1.36e-03 | 25 | 185 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | sex chromatin | 1.59e-03 | 7 | 185 | 2 | GO:0001739 | |
| GeneOntologyCellularComponent | myosin complex | 1.85e-03 | 59 | 185 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II complex | 1.90e-03 | 28 | 185 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | Barr body | 2.11e-03 | 8 | 185 | 2 | GO:0001740 | |
| GeneOntologyCellularComponent | condensin complex | 2.11e-03 | 8 | 185 | 2 | GO:0000796 | |
| MousePheno | parturition failure | 2.90e-08 | 10 | 147 | 5 | MP:0012010 | |
| MousePheno | hypermyelination | 3.66e-06 | 11 | 147 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 7.80e-06 | 13 | 147 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 1.46e-05 | 15 | 147 | 4 | MP:0005186 | |
| MousePheno | long stride length | 1.46e-05 | 15 | 147 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 1.46e-05 | 15 | 147 | 4 | MP:0002293 | |
| MousePheno | abnormal parturition | 2.25e-05 | 33 | 147 | 5 | MP:0002907 | |
| MousePheno | abnormal gestational length | 3.20e-05 | 18 | 147 | 4 | MP:0002292 | |
| MousePheno | enhanced coordination | 4.56e-05 | 38 | 147 | 5 | MP:0003858 | |
| MousePheno | dysmyelination | 4.99e-05 | 20 | 147 | 4 | MP:0013438 | |
| MousePheno | decreased oligodendrocyte number | 1.25e-04 | 25 | 147 | 4 | MP:0009808 | |
| MousePheno | abnormal oligodendrocyte morphology | 1.91e-04 | 51 | 147 | 5 | MP:0000953 | |
| MousePheno | prolonged diestrus | 2.60e-04 | 30 | 147 | 4 | MP:0009011 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.67e-06 | 10 | 180 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.67e-06 | 10 | 180 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.67e-06 | 10 | 180 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.67e-06 | 10 | 180 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.67e-06 | 10 | 180 | 4 | IPR020471 | |
| Domain | - | 1.39e-05 | 16 | 180 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.80e-05 | 17 | 180 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 1.80e-05 | 17 | 180 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.80e-05 | 17 | 180 | 4 | IPR001395 | |
| Domain | AAA | 7.86e-05 | 144 | 180 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 7.86e-05 | 144 | 180 | 8 | IPR003593 | |
| Domain | PGLYCERATE_KINASE | 9.24e-05 | 2 | 180 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 9.24e-05 | 2 | 180 | 2 | IPR015824 | |
| Domain | - | 9.24e-05 | 2 | 180 | 2 | 3.40.50.1270 | |
| Domain | - | 9.24e-05 | 2 | 180 | 2 | 3.40.50.1260 | |
| Domain | PGK | 9.24e-05 | 2 | 180 | 2 | PF00162 | |
| Domain | Core_histone_macro-H2A | 9.24e-05 | 2 | 180 | 2 | IPR021171 | |
| Domain | Phosphoglycerate_kinase_CS | 9.24e-05 | 2 | 180 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 9.24e-05 | 2 | 180 | 2 | IPR015901 | |
| Domain | IRSp53/IRTKS/Pinkbar | 2.75e-04 | 3 | 180 | 2 | IPR027681 | |
| Domain | Phosphoglycerate_kinase | 2.75e-04 | 3 | 180 | 2 | IPR001576 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.96e-04 | 14 | 180 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.96e-04 | 14 | 180 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.96e-04 | 14 | 180 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.96e-04 | 14 | 180 | 3 | IPR011704 | |
| Domain | AAA_8 | 2.96e-04 | 14 | 180 | 3 | PF12780 | |
| Domain | AAA_5 | 2.96e-04 | 14 | 180 | 3 | PF07728 | |
| Domain | AAA | 3.09e-04 | 34 | 180 | 4 | PS00674 | |
| Domain | DHC_fam | 3.68e-04 | 15 | 180 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.68e-04 | 15 | 180 | 3 | PF03028 | |
| Domain | Myosin_N | 3.68e-04 | 15 | 180 | 3 | PF02736 | |
| Domain | Dynein_heavy_dom | 3.68e-04 | 15 | 180 | 3 | IPR004273 | |
| Domain | Myosin_N | 3.68e-04 | 15 | 180 | 3 | IPR004009 | |
| Domain | Actin_CS | 4.49e-04 | 16 | 180 | 3 | IPR004001 | |
| Domain | Myosin_head_motor_dom | 4.77e-04 | 38 | 180 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.77e-04 | 38 | 180 | 4 | PS51456 | |
| Domain | Myosin_head | 4.77e-04 | 38 | 180 | 4 | PF00063 | |
| Domain | MYSc | 4.77e-04 | 38 | 180 | 4 | SM00242 | |
| Domain | NAP_family | 5.42e-04 | 17 | 180 | 3 | IPR002164 | |
| Domain | ACTINS_2 | 5.42e-04 | 17 | 180 | 3 | PS00432 | |
| Domain | NAP | 5.42e-04 | 17 | 180 | 3 | PF00956 | |
| Domain | CaMKII_AD | 5.47e-04 | 4 | 180 | 2 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 5.47e-04 | 4 | 180 | 2 | IPR013543 | |
| Domain | P-loop_NTPase | MYH3 MYH13 MYO7A ATAD5 MYH7B NVL PEX1 GBP3 AK9 LRRK1 SMC2 NLRC4 DHX30 DNAH12 ATAD2B ERCC6L2 MTREX DNAH8 DYNC1H1 | 5.55e-04 | 848 | 180 | 19 | IPR027417 |
| Domain | Myosin_tail_1 | 6.46e-04 | 18 | 180 | 3 | PF01576 | |
| Domain | Myosin_tail | 6.46e-04 | 18 | 180 | 3 | IPR002928 | |
| Domain | Actin/actin-like_CS | 6.46e-04 | 18 | 180 | 3 | IPR020902 | |
| Domain | - | ANKRD35 POTEF LRRK1 POTEE RNASEL OSBPL1A ANKDD1B AKAP13 POTEI | 6.92e-04 | 248 | 180 | 9 | 1.25.40.20 |
| Domain | Myosin-like_IQ_dom | 7.61e-04 | 19 | 180 | 3 | IPR027401 | |
| Domain | - | 7.61e-04 | 19 | 180 | 3 | 4.10.270.10 | |
| Domain | ACTINS_ACT_LIKE | 7.61e-04 | 19 | 180 | 3 | PS01132 | |
| Domain | Ankyrin_rpt-contain_dom | ANKRD35 POTEF LRRK1 POTEE RNASEL OSBPL1A ANKDD1B AKAP13 POTEI | 8.20e-04 | 254 | 180 | 9 | IPR020683 |
| Domain | PH_dom-like | ROCK2 KALRN MYO7A MPRIP GTF2H1 PLEKHM2 DGKK OSBPL1A AKAP13 FRMPD3 CADPS2 ARAP2 | 9.00e-04 | 426 | 180 | 12 | IPR011993 |
| Domain | FerI | 9.06e-04 | 5 | 180 | 2 | SM01202 | |
| Domain | FerB | 9.06e-04 | 5 | 180 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 9.06e-04 | 5 | 180 | 2 | IPR012561 | |
| Domain | Ferlin_C | 9.06e-04 | 5 | 180 | 2 | PF16165 | |
| Domain | Ferlin_C | 9.06e-04 | 5 | 180 | 2 | IPR032362 | |
| Domain | FerIin_dom | 9.06e-04 | 5 | 180 | 2 | IPR012968 | |
| Domain | FerI | 9.06e-04 | 5 | 180 | 2 | PF08151 | |
| Domain | FerB | 9.06e-04 | 5 | 180 | 2 | PF08150 | |
| Domain | RII_binding_1 | 9.06e-04 | 5 | 180 | 2 | PF10522 | |
| Domain | IMD | 9.06e-04 | 5 | 180 | 2 | PS51338 | |
| Domain | RII_binding_1 | 9.06e-04 | 5 | 180 | 2 | IPR018459 | |
| Domain | Ankyrin_rpt | 1.02e-03 | 262 | 180 | 9 | IPR002110 | |
| Domain | Ank_2 | 1.17e-03 | 215 | 180 | 8 | PF12796 | |
| Domain | IMD | 1.35e-03 | 6 | 180 | 2 | PF08397 | |
| Domain | Spectrin | 1.35e-03 | 23 | 180 | 3 | PF00435 | |
| Domain | - | ROCK2 KALRN MYO7A MPRIP GTF2H1 PLEKHM2 DGKK OSBPL1A AKAP13 CADPS2 ARAP2 | 1.48e-03 | 391 | 180 | 11 | 2.30.29.30 |
| Domain | PH | 1.54e-03 | 278 | 180 | 9 | SM00233 | |
| Domain | AAA | 1.57e-03 | 52 | 180 | 4 | PF00004 | |
| Domain | PH_DOMAIN | 1.58e-03 | 279 | 180 | 9 | PS50003 | |
| Domain | PH_domain | 1.62e-03 | 280 | 180 | 9 | IPR001849 | |
| Domain | PH | 1.74e-03 | 229 | 180 | 8 | PF00169 | |
| Domain | ATPase_AAA_core | 1.81e-03 | 54 | 180 | 4 | IPR003959 | |
| Domain | - | MYO7A ATAD5 NVL PEX1 GBP3 AK9 LRRK1 SMC2 NLRC4 DHX30 DNAH12 ATAD2B ERCC6L2 MTREX DNAH8 DYNC1H1 | 2.37e-03 | 746 | 180 | 16 | 3.40.50.300 |
| Domain | DHC_N1 | 2.49e-03 | 8 | 180 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.49e-03 | 8 | 180 | 2 | IPR013594 | |
| Domain | S_TKc | ROCK2 SLK KALRN CAMK2B CAMK2G STK26 LRRK1 STK31 RNASEL MAST4 | 2.59e-03 | 359 | 180 | 10 | SM00220 |
| Domain | ATPase_AAA_CS | 2.68e-03 | 29 | 180 | 3 | IPR003960 | |
| Domain | Spectrin_repeat | 2.68e-03 | 29 | 180 | 3 | IPR002017 | |
| Domain | ANK | 3.06e-03 | 251 | 180 | 8 | SM00248 | |
| Domain | A1pp | 3.18e-03 | 9 | 180 | 2 | SM00506 | |
| Domain | Macro | 3.18e-03 | 9 | 180 | 2 | PF01661 | |
| Domain | ANK_REPEAT | 3.22e-03 | 253 | 180 | 8 | PS50088 | |
| Domain | Semap_dom | 3.24e-03 | 31 | 180 | 3 | IPR001627 | |
| Domain | SEMA | 3.24e-03 | 31 | 180 | 3 | PS51004 | |
| Domain | Sema | 3.24e-03 | 31 | 180 | 3 | SM00630 | |
| Domain | Sema | 3.24e-03 | 31 | 180 | 3 | PF01403 | |
| Domain | Actin | 3.24e-03 | 31 | 180 | 3 | IPR004000 | |
| Domain | Actin | 3.24e-03 | 31 | 180 | 3 | PF00022 | |
| Domain | ACTIN | 3.24e-03 | 31 | 180 | 3 | SM00268 | |
| Domain | ANK_REP_REGION | 3.29e-03 | 254 | 180 | 8 | PS50297 | |
| Domain | ZF_DAG_PE_1 | 3.38e-03 | 64 | 180 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.38e-03 | 64 | 180 | 4 | PS50081 | |
| Domain | Plexin_repeat | 3.56e-03 | 32 | 180 | 3 | IPR002165 | |
| Domain | SPEC | 3.56e-03 | 32 | 180 | 3 | SM00150 | |
| Domain | PSI | 3.56e-03 | 32 | 180 | 3 | PF01437 | |
| Domain | Spectrin/alpha-actinin | 3.56e-03 | 32 | 180 | 3 | IPR018159 | |
| Domain | C1 | 3.57e-03 | 65 | 180 | 4 | SM00109 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.67e-07 | 44 | 143 | 7 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 3.14e-07 | 45 | 143 | 7 | MM14751 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 8.67e-07 | 33 | 143 | 6 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 8.67e-07 | 33 | 143 | 6 | MM14737 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.23e-06 | 9 | 143 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.23e-06 | 9 | 143 | 4 | M47817 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.91e-06 | 23 | 143 | 5 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.91e-06 | 23 | 143 | 5 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.91e-06 | 23 | 143 | 5 | MM14741 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 3.17e-06 | 11 | 143 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 6.76e-06 | 13 | 143 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 6.76e-06 | 13 | 143 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 9.39e-06 | 14 | 143 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 9.39e-06 | 14 | 143 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 9.39e-06 | 14 | 143 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 9.39e-06 | 14 | 143 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.27e-05 | 15 | 143 | 4 | MM14870 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | OFD1 CENPC NUMA1 HAUS3 SMC2 SGO1 ZWINT PPP2R5B CEP135 DYNC1H1 | 3.99e-05 | 202 | 143 | 10 | MM15362 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | OFD1 CENPC NUMA1 HAUS3 SMC2 SGO1 ZWINT PPP2R5B CEP135 DYNC1H1 | 4.34e-05 | 204 | 143 | 10 | M4217 |
| Pathway | REACTOME_CELL_CYCLE | OFD1 CENPC NSD2 KMT5A NUMA1 HAUS3 SMC2 SGO1 NCAPG2 TFDP2 ZWINT PPP2R5B SYNE2 CEP135 EXO1 ESPL1 DYNC1H1 TOP3A HSP90AB1 | 7.49e-05 | 694 | 143 | 19 | M543 |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.72e-04 | 28 | 143 | 4 | MM15188 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.82e-04 | 82 | 143 | 6 | M27626 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 2.95e-04 | 126 | 143 | 7 | MM15553 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ROCK2 SLK CENPC KALRN RAPGEF1 SGO1 LETM1 ZWINT PPP2R5B BAIAP2L1 ARHGAP29 AKAP13 BAIAP2 PLXNA1 DYNC1H1 ARAP2 HSP90AB1 | 3.09e-04 | 649 | 143 | 17 | MM15690 |
| Pathway | REACTOME_M_PHASE | OFD1 CENPC KMT5A NUMA1 HAUS3 SMC2 SGO1 NCAPG2 ZWINT PPP2R5B CEP135 ESPL1 DYNC1H1 | 3.24e-04 | 417 | 143 | 13 | M27662 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ROCK2 SLK CENPC KALRN RAPGEF1 SGO1 LETM1 ZWINT POTEE PPP2R5B BAIAP2L1 ARHGAP29 AKAP13 BAIAP2 PLXNA1 DYNC1H1 ARAP2 HSP90AB1 | 3.59e-04 | 720 | 143 | 18 | M41838 |
| Pathway | REACTOME_CELL_CYCLE | OFD1 CENPC NSD2 NUMA1 HAUS3 SMC2 SGO1 NCAPG2 ZWINT PPP2R5B CEP135 EXO1 ESPL1 DYNC1H1 TOP3A HSP90AB1 | 4.07e-04 | 603 | 143 | 16 | MM14635 |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | OFD1 CENPC KMT5A NUMA1 HAUS3 SMC2 SGO1 NCAPG2 TFDP2 ZWINT PPP2R5B CEP135 ESPL1 DYNC1H1 HSP90AB1 | 5.74e-04 | 561 | 143 | 15 | M5336 |
| Pathway | REACTOME_M_PHASE | OFD1 CENPC NUMA1 HAUS3 SMC2 SGO1 NCAPG2 ZWINT PPP2R5B CEP135 ESPL1 DYNC1H1 | 5.79e-04 | 387 | 143 | 12 | MM15364 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ROCK2 SLK KALRN RAPGEF1 LETM1 POTEE BAIAP2L1 ARHGAP29 AKAP13 BAIAP2 PLXNA1 ARAP2 HSP90AB1 | 6.64e-04 | 450 | 143 | 13 | M27078 |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 9.80e-04 | 154 | 143 | 7 | M27832 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 1.02e-03 | 113 | 143 | 6 | M16817 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 1.03e-03 | 20 | 143 | 3 | M47876 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.10e-03 | 45 | 143 | 4 | MM15344 | |
| Pubmed | ROCK2 MYH3 MYH13 CENPC NSD2 MYH7B CAMK2B POTEF KRT84 CAMK2G NUMA1 MYRIP MACROH2A1 ASIC5 CNPY2 SMC2 SGO1 PRPF8 STK31 PGK1 PGK2 LETM1 FER1L6 POTEE MIA2 IFT88 SACS COG1 CTAGE1 DGKK SYNE2 VPS35 MACF1 POTEI HSD17B4 CADPS2 DNAH8 CCDC191 GOLGB1 HSP90AB1 | 8.34e-18 | 1442 | 187 | 40 | 35575683 | |
| Pubmed | ROCK2 EPS15 SLK SORBS2 CAND1 IMPDH2 KALRN USP28 CAMK2B CAMK2G NUMA1 MACROH2A1 SMC2 PREPL PGK1 LETM1 MPRIP NF1 SYNE2 MACF1 FRMPD3 BAIAP2 CPSF2 DYNC1H1 GOLGB1 HSP90AB1 | 1.55e-11 | 963 | 187 | 26 | 28671696 | |
| Pubmed | CASP8AP2 EPS15 WDR36 IMPDH2 OFD1 CENPC ATAD5 RTN4 BAG5 NVL MACROH2A1 CNPY2 UNC45A PRPF8 NCAPG2 PREPL LETM1 DHX30 MPRIP PM20D2 SACS CEP89 SYNE2 VPS35 TOMM34 MACF1 AKAP13 SEMA6A BAIAP2 ESPL1 GOLGB1 VCL | 2.10e-11 | 1487 | 187 | 32 | 33957083 | |
| Pubmed | MYH13 NUMA1 PRPF8 FER1L6 DHX30 MPRIP NOM1 VPS35 MACF1 ALB LTF MTREX GOLGB1 HSP90AB1 | 4.20e-11 | 234 | 187 | 14 | 36243803 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | WDR36 NUMA1 NVL PNO1 MACROH2A1 UNC45A LARP4 PRPF8 PGK1 ZWINT DHX30 MPRIP PM20D2 UBL5 EXO1 CTH ALB LTF MTREX HSP90AB1 | 2.14e-10 | 624 | 187 | 20 | 33729478 |
| Pubmed | 2.35e-10 | 8 | 187 | 5 | 9224647 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 8.09e-10 | 4 | 187 | 4 | 10500239 | |
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 8.09e-10 | 4 | 187 | 4 | 14967952 | |
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 8.09e-10 | 4 | 187 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 8.09e-10 | 4 | 187 | 4 | 31479646 | |
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 16191478 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 15577209 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 10702227 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 8.09e-10 | 4 | 187 | 4 | 29764944 | |
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 17888864 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 17442338 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 28329705 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 19237748 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 28259989 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 16511129 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 7789999 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 8.09e-10 | 4 | 187 | 4 | 16508162 | |
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 15222881 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 17629694 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 10526179 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 16018803 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 8.09e-10 | 4 | 187 | 4 | 18667791 | |
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 21521174 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 8274401 | ||
| Pubmed | 8.09e-10 | 4 | 187 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 8.09e-10 | 4 | 187 | 4 | 34590152 | |
| Pubmed | SORBS2 CAND1 KALRN USP28 MYRIP ZNF521 PRPF8 PREPL OLR1 PGK1 TRIM59 DHX30 MPRIP NAA25 MIA2 IFT88 SACS COG1 OSBPL1A AKR1C3 MACF1 SMPD3 BAIAP2 HSD17B4 CADPS2 DYNC1H1 HSP90AB1 | 1.56e-09 | 1285 | 187 | 27 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAND1 WDR36 IMPDH2 OFD1 KRT84 NUMA1 MACROH2A1 SMC2 PRPF8 PGK1 DHX30 NF1 SACS SYNE2 MACF1 MACROH2A2 ALB CPSF2 MTREX HSD17B4 NNT DYNC1H1 GOLGB1 HSP90AB1 | 1.67e-09 | 1024 | 187 | 24 | 24711643 |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 4.03e-09 | 5 | 187 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 4.03e-09 | 5 | 187 | 4 | 16984997 | |
| Pubmed | 4.03e-09 | 5 | 187 | 4 | 7737980 | ||
| Pubmed | 4.03e-09 | 5 | 187 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 4.03e-09 | 5 | 187 | 4 | 17064890 | |
| Pubmed | 4.03e-09 | 5 | 187 | 4 | 10672042 | ||
| Pubmed | 4.03e-09 | 5 | 187 | 4 | 38788959 | ||
| Pubmed | 4.03e-09 | 5 | 187 | 4 | 18003893 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 WDR36 IMPDH2 CENPC CAMK2G NUMA1 PNO1 MACROH2A1 UNC45A SMC2 LARP4 PRPF8 NCAPG2 PGK1 DHX30 MPRIP GTF2H1 NF1 VPS35 MACF1 AKAP13 MACROH2A2 LTF MTREX DYNC1H1 VCL HSP90AB1 | 4.65e-09 | 1353 | 187 | 27 | 29467282 |
| Pubmed | 5.29e-09 | 13 | 187 | 5 | 17062636 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ROCK2 SLK CAND1 IMPDH2 BAG5 NUMA1 PNO1 UNC45A SMC2 LARP4 PRPF8 PGK1 LETM1 SPAG5 DHX30 MIA2 BAIAP2L1 SYNE2 VPS35 MACF1 AKAP13 CTH MTREX HSD17B4 DYNC1H1 GOLGB1 HSP90AB1 | 1.19e-08 | 1415 | 187 | 27 | 28515276 |
| Pubmed | 1.20e-08 | 6 | 187 | 4 | 19273550 | ||
| Pubmed | 1.20e-08 | 6 | 187 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.20e-08 | 6 | 187 | 4 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 1.20e-08 | 6 | 187 | 4 | 29107092 | |
| Pubmed | 1.20e-08 | 6 | 187 | 4 | 15860270 | ||
| Pubmed | 1.20e-08 | 6 | 187 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 1.20e-08 | 6 | 187 | 4 | 17255200 | |
| Pubmed | WDR36 IMPDH2 NSD2 NUMA1 NVL LARP4 PRPF8 PGK1 DHX30 NF1 ATAD2B SYNE2 MACF1 LTF MTREX NNT DYNC1H1 VCL | 1.84e-08 | 653 | 187 | 18 | 22586326 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CAND1 POTEF KRT84 STK26 MACROH2A1 AKR1C4 DYSF AKR1C1 PGK1 PGK2 POTEE BAIAP2L1 AKR1C3 AHSG MACROH2A2 ALB LTF BAIAP2 POTEI KRT38 KRT37 DYNC1H1 HSP90AB1 | 1.87e-08 | 1070 | 187 | 23 | 23533145 |
| Pubmed | ROCK2 EPS15 CAND1 IMPDH2 USP28 AP4E1 COG1 SYNE2 VPS35 POLI MACF1 ESPL1 DYNC1H1 | 2.45e-08 | 322 | 187 | 13 | 26514267 | |
| Pubmed | 2.80e-08 | 7 | 187 | 4 | 22529366 | ||
| Pubmed | 2.80e-08 | 7 | 187 | 4 | 33127481 | ||
| Pubmed | 2.80e-08 | 7 | 187 | 4 | 12562828 | ||
| Pubmed | 2.80e-08 | 7 | 187 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 2.80e-08 | 7 | 187 | 4 | 34843575 | |
| Pubmed | 2.80e-08 | 7 | 187 | 4 | 16337335 | ||
| Pubmed | CASP8AP2 CAND1 WDR36 IMPDH2 CENPC ATAD5 NSD2 USP28 NUMA1 NVL MACROH2A1 UNC45A SMC2 PRPF8 AKR1C1 AKR1C2 PGK1 BRD8 AKR1C3 TOMM34 CPSF2 MTREX | 3.32e-08 | 1014 | 187 | 22 | 32416067 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CAND1 WDR36 IMPDH2 ATAD5 NSD2 NUMA1 NVL PNO1 MACROH2A1 SMC2 LARP4 PRPF8 DHX30 NOM1 EXO1 MACF1 MACROH2A2 MTREX ESPL1 | 3.35e-08 | 759 | 187 | 19 | 35915203 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | WDR36 CENPC ATAD5 NSD2 NUMA1 NVL PNO1 MACROH2A1 PHC1 NAA25 GTF2H1 BAIAP2L1 NOM1 MACROH2A2 BAIAP2 DYNC1H1 | 3.69e-08 | 533 | 187 | 16 | 30554943 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPS15 SLK CAND1 WDR36 IMPDH2 ATAD5 USP28 RTN4 NUMA1 MACROH2A1 UNC45A PRPF8 PGK1 SPAG5 DHX30 MPRIP CRACD MACF1 GOLGB1 VCL HSP90AB1 | 3.82e-08 | 934 | 187 | 21 | 33916271 |
| Pubmed | CAND1 IMPDH2 USP28 POTEF RTN4 BAG5 NUMA1 SMC2 PRPF8 PGK1 DHX30 MACF1 FRMPD3 DYNC1H1 VCL HSP90AB1 | 4.19e-08 | 538 | 187 | 16 | 28524877 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.21e-08 | 179 | 187 | 10 | 36261009 | |
| Pubmed | 5.57e-08 | 8 | 187 | 4 | 33584538 | ||
| Pubmed | 5.57e-08 | 8 | 187 | 4 | 20837989 | ||
| Pubmed | ROCK2 SLK SORBS2 CAND1 KALRN MYO7A MTERF1 CAMK2B CAMK2G STK26 RTN4 SMURF1 PGK1 LETM1 DHX30 MPRIP CRACD NF1 SACS VPS35 MACF1 ALB BAIAP2 DYNC1H1 VCL HSP90AB1 | 6.02e-08 | 1431 | 187 | 26 | 37142655 | |
| Pubmed | 9.99e-08 | 9 | 187 | 4 | 33348080 | ||
| Pubmed | ROCK2 SLK SORBS2 CAND1 KALRN CAMK2B CAMK2G MPRIP MACF1 BAIAP2 DYNC1H1 | 1.32e-07 | 251 | 187 | 11 | 27507650 | |
| Pubmed | 1.53e-07 | 3 | 187 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 1.53e-07 | 3 | 187 | 3 | 31780644 | |
| Pubmed | 1.53e-07 | 3 | 187 | 3 | 13678667 | ||
| Pubmed | 1.53e-07 | 3 | 187 | 3 | 7626489 | ||
| Pubmed | 1.53e-07 | 3 | 187 | 3 | 21232532 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.66e-07 | 10 | 187 | 4 | 36313771 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SLK CAND1 WDR36 IMPDH2 NSD2 CAMK2B RTN4 NUMA1 MACROH2A1 UNC45A SMC2 PRPF8 PGK1 LETM1 DHX30 NF1 VPS35 LTF MTREX HSD17B4 NNT PLXNA1 DYNC1H1 VCL HSP90AB1 | 2.14e-07 | 1425 | 187 | 25 | 30948266 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | CAND1 IMPDH2 RTN4 NUMA1 MACROH2A1 PRPF8 PGK1 LETM1 DHX30 VPS35 CTH LTF MTREX HSD17B4 NNT VCL | 2.15e-07 | 607 | 187 | 16 | 39147351 |
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 3.12e-07 | 27 | 187 | 5 | 14581517 | |
| Pubmed | 3.70e-07 | 52 | 187 | 6 | 23260145 | ||
| Pubmed | EPS15 CAND1 IMPDH2 OFD1 CAMK2G BAG5 NVL OAS2 LARP4 PRPF8 NCAPG2 PGK1 PARP4 NF1 MIA2 TOMM34 AKAP13 CPSF2 NNT DYNC1H1 GOLGB1 HSP90AB1 | 3.76e-07 | 1168 | 187 | 22 | 19946888 | |
| Pubmed | 3.87e-07 | 12 | 187 | 4 | 25774556 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 3.87e-07 | 12 | 187 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 3.87e-07 | 12 | 187 | 4 | 28893949 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK ATAD5 CAMK2G RTN4 HAUS3 LARP4 PRPF8 DYSF MPRIP PARP4 NOM1 MACF1 AKAP13 BAIAP2 ESPL1 NNT VCL | 4.47e-07 | 724 | 187 | 17 | 36232890 |
| Pubmed | 5.57e-07 | 13 | 187 | 4 | 11682476 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 5.57e-07 | 13 | 187 | 4 | 15117747 | |
| Pubmed | 5.57e-07 | 13 | 187 | 4 | 24580729 | ||
| Pubmed | Nuclear Mitotic Apparatus (NuMA) Interacts with and Regulates Astrin at the Mitotic Spindle. | 6.09e-07 | 4 | 187 | 3 | 27462074 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 6.88e-07 | 182 | 187 | 9 | 31067453 | |
| Pubmed | POTEF NUMA1 PEX1 MACROH2A1 PGK1 MPRIP CRACD BRD8 BAIAP2L1 BAIAP2 POTEI DYNC1H1 GOLGB1 VCL | 7.16e-07 | 506 | 187 | 14 | 30890647 | |
| Pubmed | 7.77e-07 | 14 | 187 | 4 | 9373155 | ||
| Pubmed | 7.77e-07 | 14 | 187 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 7.77e-07 | 14 | 187 | 4 | 34400844 | |
| Interaction | ERC1 interactions | PCGF1 IMPDH2 OFD1 SMURF1 LRRK1 CEP89 VPS35 CEP135 RASSF8 KRT38 KRT37 HSP90AB1 | 1.65e-07 | 187 | 185 | 12 | int:ERC1 |
| Interaction | YWHAZ interactions | BDP1 SYNPO2 SLK SORBS2 COL6A6 CAMK2B POTEF CAMK2G BAG5 SMC2 PRPF8 PGK1 TRIM59 SPAG5 MPRIP CRACD NF1 MAST4 BAIAP2L1 CEP89 SYNE2 ARHGAP29 EXO1 MACF1 AKAP13 BAIAP2 RASSF8 MTREX DYNC1H1 VCL ARAP2 HSP90AB1 | 4.00e-07 | 1319 | 185 | 32 | int:YWHAZ |
| Interaction | AKR1C4 interactions | 4.68e-07 | 8 | 185 | 4 | int:AKR1C4 | |
| Interaction | TSPY8 interactions | 7.61e-07 | 3 | 185 | 3 | int:TSPY8 | |
| Interaction | PFN1 interactions | EPS15 CAND1 CAMK2G PGK1 SPAG5 MPRIP NF1 BAIAP2L1 COG1 SYNE2 ARHGAP29 TMF1 MACF1 AKAP13 BAIAP2 GOLGB1 VCL HSP90AB1 | 1.13e-06 | 509 | 185 | 18 | int:PFN1 |
| Interaction | KRT75 interactions | EPS15 CAND1 KRT84 NUMA1 PRPF8 SPAG5 ZWINT PM20D2 KRT38 KRT37 | 6.94e-06 | 181 | 185 | 10 | int:KRT75 |
| Interaction | DUSP16 interactions | ROCK2 OFD1 BAG5 DUSP8 PEX1 HAUS3 PRPF8 SPAG5 ZWINT ESPL1 DYNC1H1 | 1.26e-05 | 237 | 185 | 11 | int:DUSP16 |
| Interaction | CTAGE8 interactions | 1.49e-05 | 6 | 185 | 3 | int:CTAGE8 | |
| Interaction | EED interactions | PCGF1 CAND1 IMPDH2 CENPC NSD2 KMT5A STK26 NUMA1 NVL PEX1 PNO1 MACROH2A1 UNC45A SMC2 PRPF8 PGK1 PHC1 MPRIP NAA25 NOM1 VPS35 MACF1 MACROH2A2 ALB SMPD3 CPSF2 MTREX HSD17B4 DYNC1H1 HSP90AB1 | 2.14e-05 | 1445 | 185 | 30 | int:EED |
| Interaction | AKR1C1 interactions | 2.97e-05 | 20 | 185 | 4 | int:AKR1C1 | |
| Interaction | YWHAQ interactions | SLK SORBS2 MYH13 POTEF NUMA1 SMURF1 PRPF8 PGK1 TRIM59 MPRIP NF1 MAST4 CEP89 EXO1 MACF1 AKAP13 ALB BAIAP2 RASSF8 MTREX DYNC1H1 GOLGB1 VCL ARAP2 HSP90AB1 | 3.41e-05 | 1118 | 185 | 25 | int:YWHAQ |
| Interaction | CHMP4B interactions | PCGF1 SORBS2 CAND1 WDR36 IMPDH2 OFD1 NUMA1 NVL MACROH2A1 PRPF8 DHX30 MPRIP POTEE VPS35 POLI MACROH2A2 SEMA6A GOLGB1 HSP90AB1 | 4.22e-05 | 727 | 185 | 19 | int:CHMP4B |
| Interaction | CEP152 interactions | 4.23e-05 | 179 | 185 | 9 | int:CEP152 | |
| Interaction | PCM1 interactions | OFD1 USP28 HAUS3 LARP4 SPAG5 MPRIP CEP89 VPS35 CEP135 MINDY4 BAIAP2 RASSF8 KRT38 CCDC40 | 5.04e-05 | 434 | 185 | 14 | int:PCM1 |
| Interaction | CENPM interactions | 5.10e-05 | 142 | 185 | 8 | int:CENPM | |
| Interaction | KRT86 interactions | 6.57e-05 | 75 | 185 | 6 | int:KRT86 | |
| Interaction | ECT2 interactions | CAND1 WDR36 IMPDH2 OFD1 NUMA1 NVL MACROH2A1 PRPF8 TFDP2 DHX30 MPRIP POTEE PARP4 CEP135 AHSG MACF1 MACROH2A2 CPSF2 HSD17B4 DYNC1H1 HSP90AB1 | 6.85e-05 | 887 | 185 | 21 | int:ECT2 |
| Interaction | BUB1B interactions | 8.21e-05 | 195 | 185 | 9 | int:BUB1B | |
| Interaction | OFD1 interactions | IMPDH2 OFD1 USP28 HAUS3 UNC45A SPAG5 PLEKHM2 CEP89 CEP135 NNT KRT38 DYNC1H1 | 9.14e-05 | 347 | 185 | 12 | int:OFD1 |
| Interaction | LCK interactions | KALRN CAMK2G SMURF1 UNC45A MPRIP SOCS2 NF1 COG1 CEP89 TOMM34 MACF1 GOLGB1 ARAP2 HSP90AB1 | 1.00e-04 | 463 | 185 | 14 | int:LCK |
| Interaction | KIF20A interactions | ANKRD35 WDR36 IMPDH2 NUMA1 NVL MACROH2A1 LRRK1 PRPF8 DHX30 MPRIP POTEE MIA2 COG1 PLEKHM2 SYNE2 CEP135 MACF1 MACROH2A2 ALB CPSF2 HSD17B4 KRT38 HSP90AB1 | 1.01e-04 | 1052 | 185 | 23 | int:KIF20A |
| Interaction | RHOA interactions | ROCK2 SYNPO2 SLK IMPDH2 RTN4 SMURF1 NVL MACROH2A1 AK9 OLR1 LETM1 DHX30 MPRIP NF1 MIA2 BAIAP2L1 CEP89 SYNE2 ARHGAP29 MACF1 AKAP13 BAIAP2 PLXNA1 GOLGB1 ARAP2 | 1.05e-04 | 1199 | 185 | 25 | int:RHOA |
| Interaction | CCDC8 interactions | CAND1 OFD1 KRT84 NUMA1 SMC2 PRPF8 DHX30 DNAH12 NF1 SACS MACF1 ALB HSD17B4 NNT DYNC1H1 GOLGB1 HSP90AB1 | 1.20e-04 | 656 | 185 | 17 | int:CCDC8 |
| Interaction | AGAP2 interactions | 1.44e-04 | 210 | 185 | 9 | int:AGAP2 | |
| Interaction | FBXO42 interactions | ROCK2 BDP1 CAMK2B SMURF1 ZWINT MPRIP POTEE MACF1 MTREX GOLGB1 | 1.46e-04 | 259 | 185 | 10 | int:FBXO42 |
| Interaction | NDC80 interactions | ROCK2 OFD1 CENPC HAUS3 SPAG5 ZWINT CEP89 SYNE2 OSBPL1A CEP135 VCL | 1.52e-04 | 312 | 185 | 11 | int:NDC80 |
| Interaction | CCP110 interactions | 1.52e-04 | 166 | 185 | 8 | int:CCP110 | |
| Interaction | KDM1A interactions | CASP8AP2 EPS15 OFD1 NSD2 USP28 CAMK2G HAUS3 UNC45A PHC1 SPAG5 DNTTIP1 ARHGAP29 TMF1 LTF SNAPC1 BAIAP2 RASSF8 CPSF2 KRT38 GOLGB1 TTC33 | 1.56e-04 | 941 | 185 | 21 | int:KDM1A |
| Interaction | KRT3 interactions | 1.60e-04 | 88 | 185 | 6 | int:KRT3 | |
| Interaction | USP7 interactions | ANKRD35 MYH3 PCGF1 MYH13 OFD1 USP28 NUMA1 ZNF521 TSPY1 PRPF8 STK31 FER1L6 DHX30 MPRIP NOM1 VPS35 POLI TMF1 MACF1 ALB MINDY4 LTF MTREX NNT DYNC1H1 GOLGB1 | 1.73e-04 | 1313 | 185 | 26 | int:USP7 |
| Interaction | SIRT7 interactions | WDR36 IMPDH2 NSD2 NUMA1 NVL LARP4 PRPF8 PGK1 DHX30 NF1 ATAD2B SYNE2 MACF1 LTF MTREX NNT DYNC1H1 VCL | 1.78e-04 | 744 | 185 | 18 | int:SIRT7 |
| Interaction | CREM interactions | 1.81e-04 | 90 | 185 | 6 | int:CREM | |
| Interaction | YAP1 interactions | SLK CAND1 IMPDH2 POTEF RTN4 BAG5 NUMA1 SMURF1 MACROH2A1 UNC45A SMC2 PRPF8 PGK1 MPRIP POTEE BRD8 NF1 ALB RASSF8 POTEI DYNC1H1 VCL HSP90AB1 | 1.82e-04 | 1095 | 185 | 23 | int:YAP1 |
| Interaction | DSCAM interactions | 1.86e-04 | 171 | 185 | 8 | int:DSCAM | |
| Interaction | FBF1 interactions | 1.86e-04 | 171 | 185 | 8 | int:FBF1 | |
| Interaction | NHLRC2 interactions | OFD1 KRT84 CAMK2G HAUS3 SMC2 PRPF8 PGK1 MACF1 AKAP13 HSD17B4 DYNC1H1 VCL | 1.88e-04 | 375 | 185 | 12 | int:NHLRC2 |
| Interaction | SHANK3 interactions | ROCK2 ANKRD35 SLK SORBS2 KALRN CAMK2B CAMK2G RTN4 NUMA1 SPAG5 NF1 MACF1 BAIAP2 DYNC1H1 | 2.05e-04 | 496 | 185 | 14 | int:SHANK3 |
| Interaction | HNRNPU interactions | ROCK2 CAND1 WDR36 CENPC NSD2 BAG5 SMURF1 NVL PNO1 MACROH2A1 PRPF8 DHX30 GTF2H1 BAIAP2L1 TMF1 MTREX HSD17B4 ESPL1 DYNC1H1 GOLGB1 TTC33 HSP90AB1 | 2.15e-04 | 1035 | 185 | 22 | int:HNRNPU |
| Interaction | YWHAE interactions | SORBS2 CAND1 POTEF CAMK2G STK26 SMC2 PGK1 TFDP2 MPRIP CRACD NF1 MAST4 BAIAP2L1 CEP89 EXO1 MACF1 AKAP13 MINDY4 BAIAP2 RASSF8 MTREX DYNC1H1 VCL ARAP2 HSP90AB1 | 2.15e-04 | 1256 | 185 | 25 | int:YWHAE |
| Interaction | H2BC21 interactions | ROCK2 PCGF1 CAND1 ATAD5 NSD2 NUMA1 SMURF1 MACROH2A1 TSPY1 SMC2 PRPF8 PHC1 DNTTIP1 EXO1 MACROH2A2 DYNC1H1 TOP3A | 2.42e-04 | 696 | 185 | 17 | int:H2BC21 |
| Interaction | CTAGE4 interactions | 2.50e-04 | 3 | 185 | 2 | int:CTAGE4 | |
| Interaction | MTNR1B interactions | 2.53e-04 | 135 | 185 | 7 | int:MTNR1B | |
| Interaction | CEP63 interactions | 2.55e-04 | 179 | 185 | 8 | int:CEP63 | |
| Interaction | NAA40 interactions | EPS15 SLK CAND1 WDR36 IMPDH2 ATAD5 USP28 RTN4 NUMA1 MACROH2A1 UNC45A PRPF8 PGK1 SPAG5 DHX30 MPRIP CRACD MACF1 GOLGB1 VCL HSP90AB1 | 2.63e-04 | 978 | 185 | 21 | int:NAA40 |
| Interaction | NPM1 interactions | ROCK2 BDP1 CAND1 WDR36 IMPDH2 CENPC NSD2 NUMA1 NVL PNO1 MACROH2A1 LARP4 PRPF8 DHX30 CFAP54 NF1 NOM1 SYNE2 OSBPL1A MACROH2A2 MINDY4 CPSF2 PLXNA1 HSP90AB1 | 2.75e-04 | 1201 | 185 | 24 | int:NPM1 |
| Interaction | HECTD1 interactions | CAND1 WDR36 IMPDH2 ATAD5 NSD2 NUMA1 NVL PNO1 MACROH2A1 SMC2 LARP4 PRPF8 DHX30 NOM1 EXO1 MACF1 MACROH2A2 CPSF2 MTREX ESPL1 HSP90AB1 | 2.86e-04 | 984 | 185 | 21 | int:HECTD1 |
| Interaction | TRIM33 interactions | SLK CAND1 SMC2 LARP4 PRPF8 LETM1 VPS35 LTF MTREX KRT38 KRT37 GOLGB1 VCL | 2.95e-04 | 453 | 185 | 13 | int:TRIM33 |
| Interaction | SUZ12 interactions | PCGF1 SORBS2 CAND1 WDR36 KMT5A NUMA1 MACROH2A1 SMC2 PRPF8 PGK1 DHX30 NAA25 NF1 NOM1 MACROH2A2 DYNC1H1 | 3.07e-04 | 644 | 185 | 16 | int:SUZ12 |
| Cytoband | 10p15-p14 | 1.32e-06 | 6 | 187 | 3 | 10p15-p14 | |
| Cytoband | Yp11.2 | 4.35e-05 | 94 | 187 | 5 | Yp11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYp11 | 3.90e-04 | 150 | 187 | 5 | chrYp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 5.18e-04 | 90 | 187 | 4 | chr10p15 | |
| Cytoband | 5q22.1 | 8.86e-04 | 11 | 187 | 2 | 5q22.1 | |
| GeneFamily | Aldo-keto reductases | 2.30e-06 | 15 | 119 | 4 | 399 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD35 POTEF POTEE RNASEL OSBPL1A ANKDD1B POTEI ARAP2 ANKRD30BL | 3.20e-05 | 242 | 119 | 9 | 403 |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.73e-05 | 29 | 119 | 4 | 396 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 7.58e-05 | 13 | 119 | 3 | 685 | |
| GeneFamily | Myosin heavy chains | 1.19e-04 | 15 | 119 | 3 | 1098 | |
| GeneFamily | Dyneins, axonemal | 1.77e-04 | 17 | 119 | 3 | 536 | |
| GeneFamily | AAA ATPases | 4.07e-04 | 53 | 119 | 4 | 413 | |
| GeneFamily | I-BAR domain containing | 4.24e-04 | 5 | 119 | 2 | 1287 | |
| GeneFamily | Ferlin family | 6.33e-04 | 6 | 119 | 2 | 828 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.43e-03 | 206 | 119 | 6 | 682 | |
| GeneFamily | CTAGE family | 4.26e-03 | 15 | 119 | 2 | 907 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CASP8AP2 ATAD5 NSD2 KMT5A CAMK2G CASP6 SMC2 SGO1 LARP4 NCAPG2 TRIM59 LETM1 PHC1 SPAG5 ZWINT PM20D2 BRD8 MAST4 APOLD1 SYNE2 CEP135 EXO1 ESPL1 NNT | 5.47e-08 | 939 | 185 | 24 | M45768 |
| Coexpression | ZHONG_PFC_C1_OPC | CENPC KMT5A AK9 SMC2 SGO1 NCAPG2 SPAG5 ZWINT BRD8 APOLD1 CEP135 ESPL1 | 1.39e-07 | 238 | 185 | 12 | M39096 |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | ATAD5 KMT5A SMC2 SGO1 NCAPG2 TRIM59 SPAG5 ZWINT APOLD1 CEP135 ESPL1 | 8.96e-07 | 233 | 185 | 11 | M39036 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 2.05e-06 | 30 | 185 | 5 | MM853 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 4.30e-06 | 174 | 185 | 9 | M2996 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 5.32e-06 | 17 | 185 | 4 | MM826 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.67e-06 | 180 | 185 | 9 | M8239 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.50e-05 | 155 | 185 | 8 | M39041 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CASP8AP2 SYNPO2 CAND1 NSD2 PNO1 CASP6 CNPY2 SMC2 SGO1 NCAPG2 PGK1 SPAG5 ZWINT PM20D2 SOCS2 NAA25 NF1 SACS NOM1 OSBPL1A CEP135 EXO1 SEMA6A NNT PLXNA1 | 2.03e-05 | 1407 | 185 | 25 | M14427 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 2.26e-05 | 164 | 185 | 8 | M19957 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 2.29e-05 | 24 | 185 | 4 | MM766 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | CASP8AP2 CENPC ATAD5 NSD2 STK26 NVL PNO1 CASP6 HAUS3 SMC2 SGO1 NCAPG2 LETM1 SPAG5 ZWINT PM20D2 BRD8 SACS CEP135 TOMM34 MACROH2A2 SNAPC1 ESPL1 NNT TOP3A | 2.45e-05 | 1423 | 185 | 25 | M45722 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 2.71e-05 | 25 | 185 | 4 | MM480 | |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 3.14e-05 | 85 | 185 | 6 | MM802 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | EPS15 KALRN CAMK2B CAMK2G RTN4 DUSP8 MACROH2A1 PRPF8 PREPL PGK1 OSBPL1A TOMM34 DYNC1H1 HSP90AB1 | 3.69e-05 | 547 | 185 | 14 | M2110 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 EPS15 SLK CAND1 CENPC NVL LARP4 MIA2 SACS ATAD2B SYNE2 CEP135 ARHGAP29 MACF1 AKAP13 MTREX VCL ARAP2 | 3.88e-05 | 856 | 185 | 18 | M4500 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | OMA1 CASP8AP2 ATAD5 NSD2 BAG5 PNO1 CCNJ SMC2 LARP4 NCAPG2 PGK1 ZWINT DUS2 NOM1 CEP135 EXO1 AHSG MACROH2A2 CTH CPSF2 ESPL1 TTC33 HSP90AB1 | 4.25e-05 | 1290 | 185 | 23 | M80 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 5.01e-05 | 295 | 185 | 10 | M39121 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | CENPC NSD2 CAMK2B PEX1 CASP6 MACROH2A1 SMC2 TFDP2 SPAG5 ZWINT ATAD2B ESPL1 | 5.42e-05 | 426 | 185 | 12 | M9516 |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 5.53e-05 | 137 | 185 | 7 | M406 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | 5.76e-05 | 187 | 185 | 8 | M34027 | |
| Coexpression | FISCHER_DREAM_TARGETS | CASP8AP2 CAND1 CENPC ATAD5 NSD2 USP28 KMT5A HAUS3 SMC2 SGO1 NCAPG2 TRIM59 SPAG5 ZWINT BRD8 CEP135 EXO1 ESPL1 TOP3A | 5.99e-05 | 969 | 185 | 19 | M149 |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 6.62e-05 | 60 | 185 | 5 | MM847 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 8.30e-05 | 197 | 185 | 8 | M3343 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 8.90e-05 | 199 | 185 | 8 | M5893 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | 8.90e-05 | 199 | 185 | 8 | M5429 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 9.22e-05 | 200 | 185 | 8 | M304 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 9.22e-05 | 200 | 185 | 8 | M8959 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 9.54e-05 | 201 | 185 | 8 | MM500 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 1.05e-04 | 66 | 185 | 5 | MM631 | |
| Coexpression | PROVENZANI_METASTASIS_UP | 1.06e-04 | 204 | 185 | 8 | M4100 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 1.19e-04 | 36 | 185 | 4 | MM3660 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 1.32e-04 | 37 | 185 | 4 | MM630 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | SLK CENPC RTN4 SCGN PRPF8 FOXA2 PREPL PGK1 RNF157 SOCS2 CRACD MAST4 SYNE2 VPS35 TOMM34 DYNC1H1 GOLGB1 HSP90AB1 | 1.37e-04 | 946 | 185 | 18 | M39169 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CASP8AP2 ATAD5 NSD2 SMC2 SGO1 NCAPG2 PGK1 TRIM59 SPAG5 EXO1 LTF | 1.43e-04 | 402 | 185 | 11 | MM454 |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 1.70e-04 | 115 | 185 | 6 | M7484 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 1.80e-04 | 74 | 185 | 5 | MM769 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SORBS2 OFD1 BAG5 CASP6 KLHL41 UNC45A AKR1C1 SOCS2 NF1 MIA2 APOLD1 SYNE2 ERCC6L2 POLI TMF1 GOLGB1 | 2.06e-04 | 807 | 185 | 16 | M16651 |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 2.24e-04 | 121 | 185 | 6 | MM935 | |
| Coexpression | LEE_BMP2_TARGETS_DN | CASP8AP2 SYNPO2 WDR36 ATAD5 KMT5A NVL PNO1 HAUS3 SGO1 LARP4 PGK1 TRIM59 ZWINT NAA25 SACS EXO1 MTREX | 2.43e-04 | 904 | 185 | 17 | M2325 |
| Coexpression | KAN_RESPONSE_TO_ARSENIC_TRIOXIDE | 2.45e-04 | 123 | 185 | 6 | M1784 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 OMA1 CASP8AP2 SLK CENPC HAUS3 SMC2 SACS SYNE2 OSBPL1A TMF1 SNAPC1 MTREX GOLGB1 | 2.48e-04 | 656 | 185 | 14 | M18979 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 2.55e-04 | 232 | 185 | 8 | M45800 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | SLK SORBS2 SMURF1 CASP6 GBP3 OLR1 AKR1C1 PGK1 MPRIP PARP4 BAIAP2L1 SYNE2 OSBPL1A ARHGAP29 AKR1C3 MACF1 AKAP13 SEMA6A RASSF8 NNT VCL | 2.80e-04 | 1276 | 185 | 21 | M39173 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | OMA1 SORBS2 GBP3 OAS2 AK9 DNTTIP1 FANCF CFAP54 DNAH12 TMEM232 BAIAP2L1 IFT88 CEP89 SYNE2 VPS35 AKR1C3 TMF1 BAIAP2 CCDC40 | 2.82e-04 | 1093 | 185 | 19 | M41649 |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 2.85e-04 | 45 | 185 | 4 | MM1173 | |
| Coexpression | LEE_BMP2_TARGETS_DN | CASP8AP2 SYNPO2 WDR36 ATAD5 KMT5A NVL PNO1 HAUS3 SGO1 LARP4 PGK1 TRIM59 ZWINT NAA25 SACS EXO1 MTREX | 3.05e-04 | 922 | 185 | 17 | MM1068 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ROCK2 BDP1 CENPC ATAD5 NVL HAUS3 HEATR5A MACROH2A1 KLHL41 SMC2 SGO1 DYSF PHC1 ZWINT COG1 CEP135 EXO1 TMF1 CCDC40 | 2.84e-08 | 469 | 184 | 19 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 BDP1 CASP8AP2 CENPC ATAD5 RTN4 NVL HEATR5A SMC2 SGO1 LARP4 PHC1 SPAG5 BRD8 MIA2 CEP135 EXO1 TMF1 CCDC40 | 2.03e-07 | 532 | 184 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ROCK2 BDP1 CASP8AP2 CENPC ATAD5 NSD2 PNO1 HAUS3 MACROH2A1 CCNJ SMC2 SGO1 TRIM59 PHC1 SPAG5 DHX30 CRACD IFT88 ATAD2B SYNE2 CEP135 EXO1 ANKDD1B MACF1 SEMA6A CPSF2 MTREX CCDC40 HSP90AB1 | 1.31e-06 | 1257 | 184 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 CENPC ATAD5 NSD2 USP28 KMT5A MYRIP PEX1 ZNF521 CCNJ SMC2 SGO1 TRIM59 TFDP2 PHC1 SPAG5 DHX30 CRACD CFAP54 RNASEL PLEKHM2 DGKK SYNE2 CEP135 FSCN2 EXO1 ANKDD1B CADPS2 CCDC191 CCDC40 | 2.44e-06 | 1370 | 184 | 30 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 CENPC ATAD5 NSD2 USP28 DUSP8 MYRIP HAUS3 CCNJ SMC2 SGO1 FOXA2 PHC1 SPAG5 DHX30 CRACD CFAP54 RNASEL ATAD2B SYNE2 OSBPL1A CEP135 EXO1 MACF1 CCDC40 | 5.25e-06 | 1060 | 184 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ROCK2 BDP1 CASP8AP2 CENPC ATAD5 NSD2 PNO1 HAUS3 MACROH2A1 CCNJ SMC2 SGO1 TRIM59 PHC1 SPAG5 DHX30 CRACD IFT88 ATAD2B SYNE2 CEP135 EXO1 ANKDD1B MACF1 SEMA6A CPSF2 MTREX CCDC40 HSP90AB1 | 2.31e-05 | 1459 | 184 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | IMPDH2 ATAD5 NSD2 SMC2 SGO1 NCAPG2 TRIM59 SPAG5 SOCS2 EXO1 LTF CPSF2 ESPL1 | 6.13e-05 | 409 | 184 | 13 | GSM399452_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ROCK2 CASP8AP2 OFD1 CENPC ATAD5 MYH7B STK26 PNO1 HAUS3 CNPY2 SMC2 SGO1 TRIM59 SPAG5 DHX30 GTF2H1 ATAD2B DGKK CEP135 EXO1 TMF1 MACF1 RASSF8 MTREX CCDC40 | 7.28e-05 | 1241 | 184 | 25 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 BDP1 EPS15 SLK ATAD5 BAG5 MACROH2A1 SMC2 RNF157 ZWINT COG1 ATAD2B SYNE2 MACF1 MTREX GOLGB1 | 1.23e-04 | 629 | 184 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 EPS15 SLK ATAD5 KMT5A MACROH2A1 LARP4 SPAG5 ZWINT MPRIP AP4E1 COG1 ATAD2B MACF1 GOLGB1 | 1.24e-04 | 564 | 184 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 1.87e-04 | 136 | 184 | 7 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | CENPC ATAD5 NSD2 SMC2 SGO1 NCAPG2 TRIM59 RNF157 SPAG5 EXO1 ESPL1 DNAH8 | 1.92e-04 | 398 | 184 | 12 | GSM399397_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ROCK2 CASP8AP2 OFD1 COL6A6 CENPC ATAD5 HAUS3 CCNJ SMC2 SGO1 PHC1 DHX30 AP4E1 CRACD CFAP54 RNASEL MIA2 ATAD2B DGKK SYNE2 CEP135 SEMA6A MTREX CCDC40 | 2.17e-04 | 1252 | 184 | 24 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | ATAD5 NSD2 KMT5A OAS2 SMC2 SGO1 NCAPG2 SPAG5 ZWINT CCNB3 ESPL1 | 7.95e-10 | 197 | 187 | 11 | 038fd92750257d43d5e980fd06d77742b543f11a |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7A ATAD5 NSD2 MYH7B KLHL41 SGO1 NCAPG2 OLR1 RNF157 PLEKHM2 | 5.87e-09 | 183 | 187 | 10 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | CENPC KMT5A SMC2 SGO1 TRIM59 SPAG5 ZWINT APOLD1 CEP135 ESPL1 | 1.25e-08 | 198 | 187 | 10 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | CENPC KMT5A SMC2 SGO1 TRIM59 SPAG5 ZWINT APOLD1 CEP135 ESPL1 | 1.25e-08 | 198 | 187 | 10 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.31e-08 | 199 | 187 | 10 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | ATAD5 NSD2 MACROH2A1 SMC2 SGO1 NCAPG2 SPAG5 ZWINT EXO1 ESPL1 | 1.31e-08 | 199 | 187 | 10 | 4142d5b1b20212508f95841fdac4efb7655616cb |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 187 | 10 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-08 | 199 | 187 | 10 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-08 | 200 | 187 | 10 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | medial-Hematologic-Proliferating_NK/T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-08 | 200 | 187 | 10 | ab1f9f99cb4a381a642a2cfb32e7f8d276c2dda4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.37e-08 | 200 | 187 | 10 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-08 | 200 | 187 | 10 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 CENPC OAS2 ATAD2B SYNE2 MACF1 AKAP13 DYNC1H1 GOLGB1 ARAP2 | 1.37e-08 | 200 | 187 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | medial-Hematologic-Proliferating_NK/T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-08 | 200 | 187 | 10 | bfde42e00a9a6b858937de87cd19c9ed3677d954 | |
| ToppCell | medial-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-08 | 200 | 187 | 10 | 3d1895490dd262e9246eb280938239a7253451dd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-08 | 180 | 187 | 9 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-07 | 189 | 187 | 9 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-07 | 189 | 187 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 192 | 187 | 9 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 192 | 187 | 9 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-07 | 194 | 187 | 9 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.40e-07 | 194 | 187 | 9 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-07 | 194 | 187 | 9 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-07 | 194 | 187 | 9 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-07 | 194 | 187 | 9 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.46e-07 | 195 | 187 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.46e-07 | 195 | 187 | 9 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.53e-07 | 196 | 187 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.53e-07 | 196 | 187 | 9 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.60e-07 | 197 | 187 | 9 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.60e-07 | 197 | 187 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-07 | 197 | 187 | 9 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-07 | 197 | 187 | 9 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.60e-07 | 197 | 187 | 9 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.60e-07 | 197 | 187 | 9 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.60e-07 | 197 | 187 | 9 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.60e-07 | 197 | 187 | 9 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.60e-07 | 197 | 187 | 9 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.67e-07 | 198 | 187 | 9 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-07 | 198 | 187 | 9 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-07 | 198 | 187 | 9 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-07 | 198 | 187 | 9 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-07 | 198 | 187 | 9 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-07 | 198 | 187 | 9 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.74e-07 | 199 | 187 | 9 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-07 | 199 | 187 | 9 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-07 | 199 | 187 | 9 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 1.74e-07 | 199 | 187 | 9 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-07 | 199 | 187 | 9 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-07 | 199 | 187 | 9 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 1.74e-07 | 199 | 187 | 9 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-07 | 199 | 187 | 9 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 1.74e-07 | 199 | 187 | 9 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.74e-07 | 199 | 187 | 9 | c7c501ad144ac5488d0b0496554d46616f2e01a6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.81e-07 | 200 | 187 | 9 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-07 | 200 | 187 | 9 | 008f137920cc3b599376706803c111d1d0ec17ef | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.81e-07 | 200 | 187 | 9 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells-Neuroepithelial_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-07 | 200 | 187 | 9 | 0e119c2742f2be19fde8890d1227bf277ead976f | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.38e-07 | 162 | 187 | 8 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-07 | 169 | 187 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.91e-07 | 172 | 187 | 8 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-07 | 174 | 187 | 8 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-07 | 174 | 187 | 8 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.33e-07 | 179 | 187 | 8 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.33e-07 | 179 | 187 | 8 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.33e-07 | 179 | 187 | 8 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.73e-07 | 180 | 187 | 8 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-06 | 185 | 187 | 8 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.20e-06 | 185 | 187 | 8 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 185 | 187 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-06 | 187 | 187 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-06 | 189 | 187 | 8 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 190 | 187 | 8 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-06 | 191 | 187 | 8 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.52e-06 | 191 | 187 | 8 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.52e-06 | 191 | 187 | 8 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 192 | 187 | 8 | 291df12b4b5ff11fbaa43033692b8f4b5cdf65a1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 192 | 187 | 8 | 35ffe7aa9ffab85eac3326651e901c39d0119650 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-06 | 134 | 187 | 7 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-06 | 193 | 187 | 8 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-06 | 193 | 187 | 8 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-06 | 193 | 187 | 8 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.64e-06 | 193 | 187 | 8 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 1.71e-06 | 194 | 187 | 8 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-06 | 194 | 187 | 8 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.71e-06 | 194 | 187 | 8 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 1.71e-06 | 194 | 187 | 8 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-06 | 194 | 187 | 8 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 1.71e-06 | 194 | 187 | 8 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-06 | 194 | 187 | 8 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.71e-06 | 194 | 187 | 8 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.77e-06 | 195 | 187 | 8 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 195 | 187 | 8 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.77e-06 | 195 | 187 | 8 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 1.77e-06 | 195 | 187 | 8 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 195 | 187 | 8 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.77e-06 | 195 | 187 | 8 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 195 | 187 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.84e-06 | 196 | 187 | 8 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-06 | 196 | 187 | 8 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.10e-07 | 50 | 113 | 7 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.55e-04 | 49 | 113 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of BUB1 | 2.06e-04 | 52 | 113 | 5 | MORF_BUB1 | |
| Computational | Neighborhood of BMPR2 | 2.63e-04 | 85 | 113 | 6 | GCM_BMPR2 | |
| Computational | Neighborhood of CDC20 | 2.93e-04 | 56 | 113 | 5 | GNF2_CDC20 | |
| Computational | Neighborhood of CCNB2 | 3.18e-04 | 57 | 113 | 5 | GNF2_CCNB2 | |
| Drug | cloxazolam | 4.13e-09 | 4 | 184 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 4.13e-09 | 4 | 184 | 4 | ctd:D011278 | |
| Drug | tetralol | 4.13e-09 | 4 | 184 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 4.13e-09 | 4 | 184 | 4 | ctd:C018156 | |
| Drug | nocodazole | ROCK2 EPS15 MYH3 MYH13 CENPC MYH7B NUMA1 MYRIP MACROH2A1 SMC2 SGO1 ZWINT COG1 CCNB3 NOM1 ESPL1 DYNC1H1 GOLGB1 VCL | 1.24e-08 | 477 | 184 | 19 | CID000004122 |
| Drug | Hydroxysteroids | 2.05e-08 | 5 | 184 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 2.05e-08 | 5 | 184 | 4 | ctd:C010092 | |
| Drug | Medazepam | 6.12e-08 | 6 | 184 | 4 | ctd:D008472 | |
| Drug | zomepirac | 1.42e-07 | 7 | 184 | 4 | ctd:C020549 | |
| Drug | Nitrazepam | 2.82e-07 | 8 | 184 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 5.04e-07 | 9 | 184 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 5.04e-07 | 9 | 184 | 4 | ctd:D004092 | |
| Drug | cyclopentanol | 5.19e-07 | 3 | 184 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 5.19e-07 | 3 | 184 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 5.19e-07 | 3 | 184 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 5.19e-07 | 3 | 184 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.19e-07 | 3 | 184 | 3 | ctd:C530610 | |
| Drug | octyl gallate | 8.35e-07 | 10 | 184 | 4 | ctd:C016627 | |
| Drug | Glycyrrhetinic Acid | 1.22e-06 | 24 | 184 | 5 | ctd:D006034 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.30e-06 | 11 | 184 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.30e-06 | 11 | 184 | 4 | CID000013946 | |
| Drug | Flufenamic Acid | 1.61e-06 | 45 | 184 | 6 | ctd:D005439 | |
| Drug | Phenolphthalein | 1.94e-06 | 12 | 184 | 4 | ctd:D020113 | |
| Drug | tetrahydrodeoxycorticosterone | 2.06e-06 | 4 | 184 | 3 | ctd:C009413 | |
| Drug | gliquidone | 2.06e-06 | 4 | 184 | 3 | ctd:C010969 | |
| Drug | DBD-H | 2.06e-06 | 4 | 184 | 3 | CID000131382 | |
| Drug | DMBA-3,4-dihydrodiol | 2.79e-06 | 13 | 184 | 4 | CID000050096 | |
| Drug | flunisolide | 2.79e-06 | 13 | 184 | 4 | ctd:C007734 | |
| Drug | 5-alpha-Dihydroprogesterone | 3.88e-06 | 14 | 184 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 3.88e-06 | 14 | 184 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 3.88e-06 | 14 | 184 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 5.13e-06 | 5 | 184 | 3 | CID000257630 | |
| Drug | NSC36919 | 7.33e-06 | 58 | 184 | 6 | CID000235496 | |
| Drug | Clorgyline | 9.48e-06 | 168 | 184 | 9 | ctd:D003010 | |
| Drug | 9,10-phenanthrenequinone | 9.86e-06 | 61 | 184 | 6 | CID000006763 | |
| Drug | AC1L93E5 | 1.02e-05 | 6 | 184 | 3 | CID000412383 | |
| Drug | Estazolam | 1.02e-05 | 6 | 184 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 1.02e-05 | 6 | 184 | 3 | CID000439898 | |
| Drug | Glipizide | 1.02e-05 | 6 | 184 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.02e-05 | 6 | 184 | 3 | ctd:C023723 | |
| Drug | AC1L8ZBW | 1.46e-05 | 19 | 184 | 4 | CID000435356 | |
| Drug | oxcarbazepine | 1.46e-05 | 19 | 184 | 4 | ctd:C036006 | |
| Drug | 20 alpha-dihydroprogesterone | 1.71e-05 | 40 | 184 | 5 | CID000008956 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.77e-05 | 7 | 184 | 3 | ctd:C117714 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.81e-05 | 20 | 184 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 1.81e-05 | 20 | 184 | 4 | ctd:D002911 | |
| Drug | Flunitrazepam | 2.22e-05 | 21 | 184 | 4 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 2.69e-05 | 22 | 184 | 4 | CID000000418 | |
| Drug | 2-cyclohexen-1-ol | 2.82e-05 | 8 | 184 | 3 | CID000013198 | |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | 2.86e-05 | 193 | 184 | 9 | 544_UP | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 3.24e-05 | 23 | 184 | 4 | DB03461 | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.36e-05 | 197 | 184 | 9 | 5536_DN | |
| Drug | antimony trioxide | 3.42e-05 | 46 | 184 | 5 | CID000014794 | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.50e-05 | 198 | 184 | 9 | 3196_DN | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.50e-05 | 198 | 184 | 9 | 6838_DN | |
| Drug | 9,10-phenanthrenequinone | 4.57e-05 | 25 | 184 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 4.57e-05 | 25 | 184 | 4 | ctd:D011280 | |
| Drug | Budesonide | 4.70e-05 | 80 | 184 | 6 | ctd:D019819 | |
| Drug | 1,10-phenanthroline | 5.40e-05 | 82 | 184 | 6 | ctd:C025205 | |
| Drug | 1 mN-9 | 5.98e-05 | 10 | 184 | 3 | CID000122108 | |
| Drug | alpha-methylcinnamic acid | 6.50e-05 | 2 | 184 | 2 | ctd:C510582 | |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 6.50e-05 | 2 | 184 | 2 | CID000135804 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 6.50e-05 | 2 | 184 | 2 | DB07768 | |
| Drug | baccharin | 6.50e-05 | 2 | 184 | 2 | ctd:C012764 | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A | 8.84e-05 | 174 | 184 | 8 | 2452_UP | |
| Drug | fenamic acid | 1.08e-04 | 12 | 184 | 3 | ctd:C001209 | |
| Drug | methylparaoxon | 1.08e-04 | 12 | 184 | 3 | ctd:C008480 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 1.10e-04 | 31 | 184 | 4 | ctd:C017228 | |
| Drug | Digoxigenin [1672-46-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.21e-04 | 182 | 184 | 8 | 5275_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 184 | 184 | 8 | 3945_DN | |
| Drug | VAI2 | 1.38e-04 | 97 | 184 | 6 | CID003474204 | |
| Drug | 4-formyl-benzoate | 1.40e-04 | 13 | 184 | 3 | CID000012088 | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A | 1.46e-04 | 187 | 184 | 8 | 1614_DN | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 1.62e-04 | 190 | 184 | 8 | 1103_UP | |
| Drug | NADH | 1.74e-04 | 144 | 184 | 7 | DB00157 | |
| Drug | Dydrogesterone | 1.77e-04 | 14 | 184 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 1.77e-04 | 14 | 184 | 3 | CID000631219 | |
| Drug | 2,4,4'-trichlorobiphenyl | DPP10 MYH13 KALRN ATAD5 NSD2 CAMK2B CCDC175 SMC2 SGO1 NCAPG2 TRIM59 NAGS SOCS2 AP4E1 BRD8 SACS ATAD2B SYNE2 EXO1 SEMA6A SMPD3 FRMPD3 ESPL1 DNAH8 NNT | 1.83e-04 | 1411 | 184 | 25 | ctd:C081766 |
| Drug | AC1O5U9L | 1.94e-04 | 3 | 184 | 2 | CID006440811 | |
| Drug | Dirian | 1.94e-04 | 3 | 184 | 2 | CID003034337 | |
| Drug | AC1NDNJY | 1.94e-04 | 3 | 184 | 2 | CID004578722 | |
| Drug | 3-sulfanylhexyl acetate | 1.94e-04 | 3 | 184 | 2 | CID000518810 | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.94e-04 | 195 | 184 | 8 | 1162_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 1.94e-04 | 195 | 184 | 8 | 6887_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; HL60; HT_HG-U133A | 1.94e-04 | 195 | 184 | 8 | 2460_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 4702_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 4606_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 5800_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 3338_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 4732_DN | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 4709_DN | |
| Drug | chlordecone | 2.10e-04 | 67 | 184 | 5 | CID000000299 | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 5545_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 6260_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 7093_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 4811_UP | |
| Drug | drospirenone | 2.20e-04 | 15 | 184 | 3 | ctd:C035144 | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A | 2.23e-04 | 199 | 184 | 8 | 1994_UP | |
| Drug | Azathioprine | SORBS2 IMPDH2 SMC2 NCAPG2 AKR1C1 AKR1C2 NAGS SPAG5 ZWINT BAIAP2L1 EXO1 ALB LTF ESPL1 ARAP2 | 2.27e-04 | 639 | 184 | 15 | ctd:D001379 |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; PC3; HT_HG-U133A | 2.30e-04 | 200 | 184 | 8 | 7134_DN | |
| Disease | Neoplasms, Hormone-Dependent | 2.12e-07 | 3 | 177 | 3 | C0027661 | |
| Disease | distal myopathy (implicated_via_orthology) | 5.97e-07 | 12 | 177 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | Hermaphroditism | 2.10e-06 | 5 | 177 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 2.10e-06 | 5 | 177 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.10e-06 | 5 | 177 | 3 | C0033804 | |
| Disease | Intersex Conditions | 2.10e-06 | 5 | 177 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.10e-06 | 5 | 177 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 7.30e-06 | 7 | 177 | 3 | C0036875 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 3.58e-05 | 2 | 177 | 2 | C1839840 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 3.58e-05 | 2 | 177 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 3.58e-05 | 2 | 177 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 3.58e-05 | 2 | 177 | 2 | 614279 | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.49e-05 | 12 | 177 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.81e-05 | 13 | 177 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | pulmonary emphysema (is_marker_for) | 7.36e-05 | 14 | 177 | 3 | DOID:9675 (is_marker_for) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 9.16e-05 | 15 | 177 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Retinal Neovascularization | 1.07e-04 | 3 | 177 | 2 | C0035320 | |
| Disease | auditory system disease (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:2742 (implicated_via_orthology) | |
| Disease | Wolf-Hirschhorn syndrome (implicated_via_orthology) | 2.13e-04 | 4 | 177 | 2 | DOID:0050460 (implicated_via_orthology) | |
| Disease | N-methylpipecolate measurement | 3.54e-04 | 5 | 177 | 2 | EFO_0800988 | |
| Disease | Endometrioma | 4.37e-04 | 161 | 177 | 6 | C0269102 | |
| Disease | Endometriosis | 4.37e-04 | 161 | 177 | 6 | C0014175 | |
| Disease | 4p partial monosomy syndrome | 5.28e-04 | 6 | 177 | 2 | cv:C1956097 | |
| Disease | WOLF-HIRSCHHORN SYNDROME | 5.28e-04 | 6 | 177 | 2 | 194190 | |
| Disease | cortolone glucuronide (1) measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0800552 | |
| Disease | X-12112 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0800705 | |
| Disease | complement component C9 measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0020282 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 7.37e-04 | 7 | 177 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Pitt-Rogers-Danks Syndrome | 9.78e-04 | 8 | 177 | 2 | C0796117 | |
| Disease | cancer (implicated_via_orthology) | 1.22e-03 | 268 | 177 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Wolf-Hirschhorn Syndrome | 1.25e-03 | 9 | 177 | 2 | C1956097 | |
| Disease | mean platelet volume | COL6A6 KALRN ATAD5 NUMA1 SMURF1 MACROH2A1 PGK1 MPRIP DNTTIP1 BRD8 MAST4 ATAD2B SYNE2 ESPL1 NNT | 1.30e-03 | 1020 | 177 | 15 | EFO_0004584 |
| Disease | Asthma | 1.39e-03 | 80 | 177 | 4 | C0004096 | |
| Disease | Intellectual Disability | 1.58e-03 | 447 | 177 | 9 | C3714756 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 1.65e-03 | 39 | 177 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | Parkinson Disease | 1.74e-03 | 85 | 177 | 4 | C0030567 | |
| Disease | Sclerocystic Ovaries | 1.80e-03 | 144 | 177 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.80e-03 | 144 | 177 | 5 | C0032460 | |
| Disease | amino acid metabolic disorder (is_implicated_in) | 1.90e-03 | 11 | 177 | 2 | DOID:9252 (is_implicated_in) | |
| Disease | Paranoia | 1.90e-03 | 11 | 177 | 2 | C1456784 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.91e-03 | 41 | 177 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | renal cell carcinoma | 2.05e-03 | 42 | 177 | 3 | EFO_0000681 | |
| Disease | temporal pole volume measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0010334 | |
| Disease | Zellweger Spectrum | 2.67e-03 | 13 | 177 | 2 | C3658299 | |
| Disease | Zellweger-Like Syndrome | 2.67e-03 | 13 | 177 | 2 | C0751594 | |
| Disease | birth weight | 2.93e-03 | 399 | 177 | 8 | EFO_0004344 | |
| Disease | myopathy (implicated_via_orthology) | 3.01e-03 | 48 | 177 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 3.11e-03 | 14 | 177 | 2 | C1960469 | |
| Disease | HIV Infections | 3.49e-03 | 103 | 177 | 4 | C0019693 | |
| Disease | HIV Coinfection | 3.49e-03 | 103 | 177 | 4 | C4505456 | |
| Disease | ovarian carcinoma (is_implicated_in) | 3.57e-03 | 15 | 177 | 2 | DOID:4001 (is_implicated_in) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.57e-03 | 15 | 177 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 3.57e-03 | 15 | 177 | 2 | cv:C3711387 | |
| Disease | Adrenoleukodystrophy, Neonatal | 3.57e-03 | 15 | 177 | 2 | C0282525 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.60e-03 | 169 | 177 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Retinitis Pigmentosa | 3.61e-03 | 104 | 177 | 4 | C0035334 | |
| Disease | eosinophil count | WDR36 MTERF1 KMT5A CAMK2G SMURF1 GSDMB OAS2 DYSF TRIM59 PHC1 DUS2 NAA25 TMEM232 POLI EXO1 AKAP13 LTF NNT | 3.75e-03 | 1488 | 177 | 18 | EFO_0004842 |
| Disease | Zellweger Syndrome | 4.06e-03 | 16 | 177 | 2 | C0043459 | |
| Disease | response to methotrexate | 4.06e-03 | 16 | 177 | 2 | GO_0031427 | |
| Disease | cardiac troponin I measurement | 4.28e-03 | 176 | 177 | 5 | EFO_0010071 | |
| Disease | testosterone measurement | CCDC73 TRPM2 AKR1C4 SCGN LARP4 AKR1C2 NLRC4 SOCS2 SEMA3D NF1 BAIAP2L1 DGKK SYNE2 AKR1C3 ANKDD1B MACF1 | 4.39e-03 | 1275 | 177 | 16 | EFO_0004908 |
| Disease | Ciliopathies | 4.41e-03 | 110 | 177 | 4 | C4277690 | |
| Disease | leukemia | 4.43e-03 | 55 | 177 | 3 | C0023418 | |
| Disease | attempted suicide | 4.49e-03 | 178 | 177 | 5 | EFO_0004321 | |
| Disease | Muscle hypotonia | 4.59e-03 | 17 | 177 | 2 | C0026827 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 4.59e-03 | 17 | 177 | 2 | C0751883 | |
| Disease | cyclic adenosine monophosphate measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0010473 | |
| Disease | electrocardiography | 4.88e-03 | 530 | 177 | 9 | EFO_0004327 | |
| Disease | stroke outcome severity measurement | 5.00e-03 | 114 | 177 | 4 | EFO_0009603 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 5.14e-03 | 18 | 177 | 2 | EFO_1000649, HP_0000131 | |
| Disease | cystathionine measurement | 5.72e-03 | 19 | 177 | 2 | EFO_0010474 | |
| Disease | lysophosphatidylcholine 20:5 measurement | 5.72e-03 | 19 | 177 | 2 | EFO_0010364 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDCVADLKGKEVKRA | 91 | Q15173 | |
| KLLDFCKSKDIVLVA | 201 | P17516 | |
| KALETLNSCKKLGRD | 1726 | Q96QE3 | |
| KDCVGSKESALAKID | 1746 | A6H8Y1 | |
| SLLIFAEKKRAAFKC | 1926 | Q96N23 | |
| DEGKASSAKQRLKCA | 211 | P02768 | |
| IDLKEALEKRKLFAC | 346 | Q9UL15 | |
| KKFAVALSGLIEEKC | 46 | Q96RT6 | |
| KDSLVSSLQFCKAKD | 611 | Q9P2I0 | |
| SRLDELCNDIATKKK | 136 | Q9H0E9 | |
| KLLDFCKSKDIVLVA | 201 | P42330 | |
| DKSIEFIDKAKLSSC | 226 | Q13202 | |
| EKRKDVLNSLAKCLG | 271 | Q8TAX9 | |
| NCLSAAEDKKLKSVA | 296 | Q9P0M6 | |
| EKTVKNCLALADDKK | 291 | O75367 | |
| NCLALADDKKLKSIA | 296 | O75367 | |
| KSISADCAKDKALQL | 966 | Q12802 | |
| ALSCLLLASKFEEKE | 86 | Q5T5M9 | |
| KISFVDCSKIKLLEA | 131 | P32929 | |
| SLTKEELNKALCAAV | 806 | Q8WZ64 | |
| DKSALILACEKGSAE | 186 | Q8N283 | |
| RKAEAENKAAALACK | 296 | Q7L2E3 | |
| LKKILVCDSKSFGRD | 1146 | Q9UKL3 | |
| LKSDEKLFKCGSVVA | 661 | Q8N608 | |
| AVCKKDKLQLLGATA | 1196 | Q8WWL7 | |
| SELLEKAAKCIGKFV | 331 | Q9UPM8 | |
| KSLLGKDVLFLKDCV | 86 | P07205 | |
| LNNCKTTADELKKLI | 156 | Q8NHQ8 | |
| VKKDSFFLDLSCEKS | 181 | O15381 | |
| KACQAKSEALVLREK | 251 | O75665 | |
| LKAKIQKLAESLESC | 226 | Q96LR9 | |
| NSELSLSCKKEKDIL | 631 | A5A3E0 | |
| AKCKLELATKAQSLQ | 756 | Q5KSL6 | |
| KNIVKKCLELFSELA | 406 | P08238 | |
| GEATLSDAKCKLADL | 416 | Q9NSB2 | |
| AKAKADCDISRLKEQ | 951 | Q6WCQ1 | |
| LKDKVLTALETCKAQ | 321 | Q9NPI8 | |
| CDSTNAAIAKQALKK | 186 | Q9NQR1 | |
| KGSESCNLFLKSLKE | 61 | Q9NPP4 | |
| KLTASKNCLEKLFEE | 356 | Q38SD2 | |
| DKCGTQKLLDDATLA | 206 | O76014 | |
| KDFLKDIDLICSNAL | 1021 | Q9ULI0 | |
| ASKDAKKQLLCGAAI | 236 | P12268 | |
| DKCGTQKLLDDATLA | 206 | O76015 | |
| DILSDACSKLQEQKK | 546 | O95202 | |
| KELSNCASLEKLELA | 146 | Q96DD0 | |
| KCFNDLKAEELLLKI | 86 | P55212 | |
| KDLFTCTIKRLKAAD | 566 | Q86VP6 | |
| ANAKCSSLEKAKLRL | 1456 | A7E2Y1 | |
| KGLDCDTVTQAKEKL | 1521 | Q9UIW2 | |
| TNQIDALAKKLKLEC | 3921 | Q96JB1 | |
| LKSQAATKNLSDACK | 581 | O96028 | |
| LEQKEAFLKACTLAR | 1056 | O60229 | |
| LDCEDLKTGLTNKAK | 471 | Q6ZR08 | |
| DGLKDLLDEKKFIDC | 21 | O60662 | |
| LLDEKKFIDCTLKAG | 26 | O60662 | |
| KLAAQLDKKRDDFCK | 381 | Q9H0R5 | |
| FKKKDTILSLNACES | 1611 | P00451 | |
| EAKAQLAKSCKVLVD | 191 | Q8N159 | |
| KSLLGKDVLFLKDCV | 86 | P00558 | |
| CKETKDVSALTKAAD | 121 | Q9NRX1 | |
| KEVNLGLLAKKADLC | 336 | Q9UKK3 | |
| CLQEVFDKRAATKLK | 361 | Q9NY59 | |
| DILDKTGDKLKFCLF | 96 | P29728 | |
| EKSQEKCLSLDAKLL | 166 | P78380 | |
| AADLKKSLEKAQSCQ | 356 | Q9BXW6 | |
| KSDDKLCGTLKSEIA | 3221 | Q9UPN3 | |
| NSELSLSCKKEKDVL | 631 | Q6S8J3 | |
| GKCDACLSDKAQLLL | 961 | Q52LW3 | |
| SLKKCARETADLKFL | 106 | Q66GS9 | |
| EAKAFCLEALKLTTK | 1006 | Q14674 | |
| NSCGDLKLALEKAKD | 156 | Q13099 | |
| KLCKDVLAASADFTA | 1166 | Q86XA9 | |
| KFIADGCKEALLEEK | 176 | Q9UHR4 | |
| NFCSALDSKLKVKLD | 516 | Q8WTW3 | |
| ELKKDLAILEAKLCF | 306 | P0C221 | |
| AKLCFFTDNKEKLDD | 316 | P0C221 | |
| DSLCKLKFRLDASDK | 1611 | Q9UFH2 | |
| DEADLAKKKNLDCSR | 621 | Q03188 | |
| KEATEAAKCNLLAEK | 211 | P02765 | |
| AKCLESEKDGVLNKV | 626 | Q96ST8 | |
| KLELALKFKELRASC | 1661 | Q5JV73 | |
| GKLKCEAVVADVLDK | 421 | P51659 | |
| LEAKCKRQKAEAAEK | 231 | Q6ZU35 | |
| TCAAANEERKKLAAL | 376 | Q4G0X9 | |
| EKTLKKSAFLEAQCL | 216 | Q8NCU4 | |
| CSLKKELKKAASDLI | 211 | Q6ZRK6 | |
| ADNVKDKLCSKRTDL | 156 | Q9Y2B0 | |
| AKDALEESLLLKDCK | 56 | Q8IZI9 | |
| ILEGAALDEALKTCK | 71 | Q68CZ6 | |
| ALDEALKTCKTSDLK | 76 | Q68CZ6 | |
| AENGLLEKIKLCLSK | 11 | Q9NY37 | |
| LVDAKKQSTKLCALD | 1086 | Q86UW7 | |
| NSAVSTEDLKECLKK | 111 | Q71RC2 | |
| KSSQAKELLRCEKLD | 1666 | O15021 | |
| KELLRCEKLDSKLAN | 1671 | O15021 | |
| KCAKAKEALELTDTG | 1296 | Q14204 | |
| TKDCGKLSKDQFALA | 271 | P42566 | |
| RKKCAEEAQLISSLK | 416 | P42566 | |
| DKSKKLAEQAAAIVC | 416 | Q9NX74 | |
| FSKLLETKCKAVEDS | 806 | Q5T890 | |
| CNLKALNTAKKGLID | 436 | Q9UNA4 | |
| NKDGKIQKSELALCL | 256 | O76038 | |
| KGFKLLTDEKSCQDV | 351 | Q9NQ36 | |
| AFLANEEKAIRLCKA | 4026 | Q9NZJ4 | |
| AKTAKKCSLDQLDDA | 1936 | O75923 | |
| STLAKAICKEAFDKL | 606 | O43933 | |
| NLLLASKCKGAAVKL | 141 | Q13555 | |
| LDGEILKKESLRAKC | 2096 | A6NMZ7 | |
| QLEKELSAALQDKKC | 361 | Q14980 | |
| LSAALQDKKCLEEKN | 366 | Q14980 | |
| LCLERLSSGKDKNKS | 171 | Q9BSM1 | |
| EKLALAKFVAQESKC | 721 | Q8IWE5 | |
| ESTKLLADLKKCGDL | 21 | Q96PC5 | |
| TLEFKAGKLAFKDCD | 211 | O14926 | |
| KCEKQLALKEAAGAA | 256 | Q9Y261 | |
| LGDAKKTCDALQAKV | 1066 | Q13423 | |
| AAKSAKACDLAKFEN | 1721 | Q2WGJ9 | |
| LESKVDKKCFADSLE | 416 | Q9NQC3 | |
| LERIKAGKAACIDKL | 1611 | Q5TCS8 | |
| NLLLASKCKGAAVKL | 141 | Q13554 | |
| KAKEADIEKLNQALC | 1021 | Q96R06 | |
| FDIASVKALDNKLCS | 621 | Q96PX1 | |
| KDFLKKCLEKNVDAR | 266 | Q9H2G2 | |
| KLADFALLCLDGKRK | 586 | P02788 | |
| EAEALSLKLKTVKCN | 4311 | Q8WXH0 | |
| SAALEKLKLLCGEEK | 41 | A6NDU8 | |
| KKLIEKFQKCSADES | 401 | Q9P289 | |
| KKIAELLCKRGASTD | 286 | Q05823 | |
| CLKKSFQDSLEDIKK | 6 | Q5FBB7 | |
| LDSIICVKSKLKQFD | 106 | O14508 | |
| KDLKLGTNIKDLCAA | 361 | Q86UG4 | |
| FIDSKKACEKLLASI | 736 | P11055 | |
| LREKADLATKCLQGK | 841 | Q5C9Z4 | |
| NSELSLSCKKEKDFL | 631 | P0CG38 | |
| SKKALDKGCENLQIL | 301 | Q8NH85 | |
| DSDLLAFGCKKVILK | 171 | Q9UQ84 | |
| DKIGLLLAAKACADI | 396 | Q96E52 | |
| LTKKAEDCFRAAALA | 286 | Q8IYS1 | |
| AKCKASVFEALDSAL | 721 | O94875 | |
| SGKCSLEDLKLAKSL | 326 | Q14188 | |
| RLTVLCAKNLAKKDF | 16 | Q9HCE7 | |
| LKACLLEDFLDKSAS | 366 | Q96N87 | |
| CERAESLAKIKSKAF | 256 | Q16533 | |
| KERVELCKLAGKDAN | 111 | O95025 | |
| KLLSCGADIEVKNKA | 156 | A7E2S9 | |
| GDALDKCQAELKKLR | 131 | Q9UQB8 | |
| EKLLQLSAAAVDKGC | 801 | O75969 | |
| ETLLKAGCDLKAVDK | 351 | A6NHY2 | |
| KLLDFCKSKDIVLVA | 201 | Q04828 | |
| KLLDFCKSKDIVLVA | 201 | P52895 | |
| AVIFKTKLAKDICAD | 61 | P51671 | |
| KKASGKILEAIENDC | 271 | Q86XI2 | |
| CLKVEKFGDLILKAT | 1896 | Q6P2Q9 | |
| EEVLKKGFAEKCRLA | 201 | Q9BXU1 | |
| FAGSNKIAEILCKDL | 266 | P0CW01 | |
| AVKDCTEALKLDGKN | 246 | Q15785 | |
| FAGSNKIAEILCKDL | 266 | A6NKD2 | |
| DLFAECAKIDEKGLK | 241 | P32780 | |
| EFVVDSQKKDKLLCS | 41 | O95229 | |
| LACKERDAAKKEIKN | 516 | P82094 | |
| FAGSNKIAEILCKDL | 266 | Q01534 | |
| EAKSKCKSIALLLTD | 371 | Q9UMS6 | |
| VLQKLLFEGDSKADC | 466 | Q4G0A6 | |
| LCEKKAQIAIDIKSA | 821 | P42285 | |
| LDKVDQKKLLRCATS | 806 | Q13905 | |
| CLEQAKLLFSDGEKV | 121 | Q9H147 | |
| DAICKAQELKDKKLA | 611 | C9JQI7 | |
| TQCALAASKLLKKPD | 651 | Q96QK1 | |
| AALACSKILKELSKE | 651 | O94759 | |
| IKVLLKKNDDALFVC | 121 | Q9H2E6 | |
| VKCNTDDTIGDLKKL | 16 | Q9BZL1 | |
| KCASCLKEFRSKQDL | 1066 | Q96K83 | |
| TKRALIQCAKDIAKA | 1011 | P18206 | |
| IFLAEKKFNDKIDCL | 321 | Q99551 | |
| VAKKRNLEDKCSSLK | 941 | Q9UKX3 | |
| DCAKLKRLLKETAFK | 186 | P21359 | |
| DLQDKNCLLETAKLK | 601 | O75116 | |
| NCLLETAKLKLEKEF | 606 | O75116 | |
| SPSAELDKKANLLKC | 786 | P78364 | |
| TKKLNGLADLEACIK | 526 | Q4J6C6 | |
| KCLLELNAKAASLFE | 951 | Q96RU2 | |
| AFDLKKKNLACEESK | 316 | O95347 | |
| AELEADLKLICDGKK | 586 | Q13472 | |
| FAGSNKIAEILCKDL | 266 | P0CV98 | |
| FAGSNKIAEILCKDL | 266 | P0CW00 | |
| GTCDRLVKAAKSAKL | 221 | Q9NVE5 | |
| ASILLSKLFDDLKCD | 371 | Q9H3U1 | |
| LEQKKKSFLTALCDV | 196 | Q8IWR1 | |
| LLEGCAEKSKQLKDE | 51 | Q6PID6 | |
| LAQKSDFCLKLEEGL | 821 | Q8NI36 | |
| LTDLSNSLEKCKEQK | 2321 | Q14789 | |
| KELCNALADKISLKD | 1281 | Q13402 | |
| QLKDVFSKCKGDLLE | 811 | Q14CX7 | |
| LSELKQKLDEEGSKC | 36 | Q8NFW9 | |
| EELKKKFSAVSLCNI | 631 | Q8NFW9 |